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ABSTRACT

Toxoplasma gondii, an obligate intracellular parasite, has the ability to differentiate
between actively replicating tachyzoites and encysted bradyzoites. Bradyzoites within the
tissue cysts are resistant to both the immune system and the chemotherapy. They are not
only responsible for the transmission of the parasites via camivorism, but also the source
for recrudescence of infection in immunocompromised patients. Molecular mechanisms
triggering the differentiation between the two forms are not clear. However, studies have
shown that T.gondii expresses two distinct lactate dehydrogenases (LDH) during its stage
conversion; LDH1 during the tachyzoite and LDH2 during the bradyzoite stage. LDH2
shows transcriptional regulation by being exclusively expressed during bradyzoite stage
that resembles anaerobic condition. Whereas LDH1 transcription is found in both stages
and indicates a translational suppression of LDH 1 in bradyzoites. Regulatory activities of
5' and 3 'untranslated region have been reported in other eukaryotic systems indicating
their role in gene expression. Aim of this study is to investigate the role of upstream and
downstream sequences of LDH1 in translational suppression and to observe the effect of
removal of suppression of LDH2 gene on the parasite’s phenotype. For the first part of
this study, transgenic parasite strains were generated to express GFP under the influence
of upstream and/or downstream sequence of LDH1. GFP expression and localization was
measured during both stages of the parasites and was found decreased in bradyzoite
stage. These results indicates that the upstream and down stream sequences of LDH1
could be responsible for the lowered GFP expression. Possible effects on phenotype and
future work are discussed.
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CHAPTER 1
INTRODUCTION
1.1 Toxoplasma gondii
Toxoplasma gondii is an unusually promiscuous intracellular protozoan parasite
that has the ability to infect virtually any vertebrate. It belongs to phylum Apicomplexa
and is closely related to other protozoan parasites e.g. Plasmodium and Cryptosporidium
(Dubey, 1994). Based on its worldwide distribution, T. gondii is the most ubiquitous
parasite of the vertebrates that infects up to 50% of the human population (Dubey, 1977).
Infection occurs through ingestion of viable tissue-cyst in undercooked meat or by
contact with the oocysts shed in cat’s feces. Infection in healthy individuals remains
asymptomatic except for some mild clinical symptoms. However, this infection progress
to a chronic state without complications, persists for the life time of the host, and remains
clinically unapparent. On the contrary, primary infection during pregnancy cause trans
placental transmission of the parasite and can lead to spontaneous abortion or severe
congenital birth defects such as blindness, mental retardation, and hydro encephalopathy.
Severity of infection depends on stage of pregnancy (Luft and Remington, 1992). Being
an opportunistic pathogen, T. gondii, can reactivate the chronic infection in conditions
where host immune system is compromised e.g. patients receiving cytotoxic
chemotherapy or with HIV/AIDS. Unrestricted parasite growth leads to severe
toxoplasmosis in such patients (Luft and Remington, 1988; Mills, 1986). In recent years,
there has been a dramatic increase in the population of immunocompromised individuals
and T. gondii can cause intracerebral focal lesions, leading to toxoplasmic encephalitis in
this group (Wong and Remington, 1993).

1
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Infection in the intermediate host (humans, cattle, birds) involves stage
conversion between the two asexual forms of T. gondii i.e. rapidly multiplying
tachyzoites which is responsible for acute toxoplasmosis and slowly dividing bradyzoites
which is dormant encysted form found predominantly in brain and muscles. Tachyzoites
are effectively cleared away by host’s immune system (Dubey, 1994) while bradyzoites
remain protected from immune response for the remaining life span of the host (Soete et
al., 1993) and act as a source of infection for transmission via camivorism. This stage
conversion is reversible and is responsible for the reactivation of a chronic infection into
an acute one during period of lowered immunity (Freyre, 1995). The differentiation of
these two forms of T. gondii involves morphological and molecular biological changes
like stage specific antigen expression and alterations in metabolism (Yang and Parmley,
1997).
Current medicinal regimen (Sulfonamide and pyrimethamine) can effectively
eliminate the tachyzoites but do not remove chronic bradyzoite stage (Cooper et al.,
1991). No effective treatment is available for chronic toxoplasmosis to date (Boothroyd
et al., 1997; Black and Boothroyd, 2000). Inability to completely eliminate the infection
and toxic side effects of the existing drugs represents a critical need for a safer and more
effective chemotherapeutic agent. Hence we need to decipher more about T.gondii cell
biology in order to develop new strategies that could help in elimination of parasite
infection.

2
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1.1.1 Parasite strains and host cells
Toxoplasma gondii can be grown and maintained in virtually any mammalian cell
type e.g. HeLa, Vero, macrophages, T cells, and human foreskin fibroblast (HFF)
(Boothroyd et al., 1997; Mavin et al., 2004). Parasites infect monolayer cultures more
efficiently as compared to suspension cultures, probably because contact and invasion is
easy in monolayers. HFF are the most commonly used host cells as they give high
parasite titer with minimal cell debris, and are resistant to metabolic inhibitors e.g. drugs
used for parasite selection. Being human cells they also provide comparability to clinical
infections (Roos et al., 1994; Freyre, 1995).
Many T.gondii laboratory strains are used and show differences in their rate of
replication, virulence, and ability to form cysts. RH strain is easiest to grow both in cellcultures and in animals and most commonly used because of its high virulence, rapid
replication, and efficient host cell lysis (Sibley and Boothroyd, 1992). However, RH
strain has weak ability to differentiate into bradyzoite stage or to from tissue cysts. RH is
also incapable of making gametes in feline hosts (Freyre, 1995). Two other common
strains are CEP derived from cat (Pfefferkom et al., 1977) and PLK from sheep (Kasper
and Ware, 1985). PLK strain is capable of producing tissue cysts and is ideal for
bradyzoite differentiation and development studies. PLK which is a subclone of ME-49
strain can complete sexual cycle of parasite in feline host. Replication rate of PLK strain,
however, is much slower than RH strain (Soete et al., 1993; Boothroyd et al. 1997).

3
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1.1.2 Toxoplasma gondii as experimental model for phylum Apicomplexa
Unlike other members of the phylum apicomplexa that are difficult to culture or
propagate in the laboratory, T. gondii is amenable to genetic manipulations, easy to
propagate using standard culture procedures and has emerged as a model for studying
intracellular parasitism. Haploid genome of the parasite during asexual cycle has
facilitated the generation of loss-of-function mutants (Black and Boothroyd, 1998). Data
base of T.gondii genome is also well established (http://toxodb.org: Kissinger et al.,
2003).

1.1.3 Genetic manipulations in T.gondii
For the introduction of different forms of nucleic acids, electroporation is one of
the most efficient mean for T.gondii transformation. Electric pulse generated during
electroporation is believed to form small pores within the parasite cell membrane and
facilitates the uptake of plasmid or nucleic acid. Once taken up by the parasites these
plasmids serve as vehicle for stable or transient gene expression depending on whether it
integrate into parasite genome or not (Boothroyd et a l, 1995 and Roos et al., 1994).
Stable DNA transformation results in permanent expression of transgenes by
random or directed integration into the parasite’s genome (Donald and Roos, 1994).
Episomal vectors are used for stable transformation without integration into the parasite’s
genome, eliminating the possibility of mutation due to random integration. Several
strategies have been established for stable expression of transgene. One such stable DNA
transformation is based on complementation of naturally occurring tryptophan
auxotrophy in T.gondii. Prototroph was achieved by expressing E.Coli trpB gene

4
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encoding tryptophan synthase that catalyzes formation of tryptophan from supplemented
indole or serine and eliminates the tryptophan dependency of T.gondii on host cells.
Efficient T.gondii selection was made by tryptophan-depleted media and cytokines
(IFNy) treated host cells (Pfefferkom, 1984). Tryptophan starvation was enhanced by
IFNy treatment. Transforming vector encoding trpB gene integrated into parasite genome
by non homologous recombination (Sibley et a l, 1994) and the transformants were stable
in the absence o f continued selection.
Transient gene expression, on the other hand, is achieved when a plasmid fails to
integrate into the parasite genome (Roos et al., 1994). Expression is most efficient when
it is under the control of T.gondii gene promoters such as ^-tubulin (TUB1), rhoptry
protein (ROP1), and surface antigen (SAG1) (Roos et a l, 1994; Soldati et al., 1995),
TUB1 being the strongest and SAG1 being the weakest promoter. Limitations to transient
expression are short duration of expression and significant variation in the amount of
genetic material taken up by the cell resulting into heterogenous population. Several
reporter genes have been successfully used for transient gene expression such as /?galactosidase (lacZ), ^-glucuronidase igus), chloramphenicol acetyltransferase (cat), and
luciferase. However, cat appears to function more effectively in T.gondii as compare to
other reporter genes.
Vectors having small sequences of genomic DNA usually integrate by
nonhomologous or random recombination (Tomavo, 2001; Sibley et al., 1994).
Transformation vectors based on sequences from dihydrofolate reductase-thymidyle
synthase gene (DHFR-TS) have been developed for T. gondii genetic transformation
(Donald and Roos, 1993). DHFR-TS gene was engineered to harbor mutations analogous

5
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to those found in DHFR-TS gene of pyrimethamine-resistant Plasmodium falciparum to
introduce resistance for pyrimethamine in T.gondii. In more than 5% of the transformed
parasites, DHFR-TS gene was reported to integrate into parasite genome by non
homologous recombination. DHFR-TS mini gene has been used by several investigators
to disrupt non essential genes by insertional mutagenesis (Donald and Roos 1995; Donald
et al, 1996). Insertion at the hypoxanthineguanins phosphoribosyl transferase (HXGPRT)
and Uracil phosphoribosyl transferase (UPRT) loci, which code for enzymes of purine
and pyrimidine salvage pathway respectively, has been successfully generated.
As with transient expression, insertional mutagenesis has its own limitations,
Such as the function of an essential gene could be compensated due to complementation.
500-bp sequence has been reported to permit the maintenance of bacterial plasmid as
episomal DNA (Black and Boothroyd, 1998). This sequence could incorporate into
vectors bearing fragments of the parasite genome and vectors can replicate autonomously
with in T.gondii. On the other hand, Pyrimethamine resistant parasites pose a serious
hazard because antifolates are used for the treatment of acute toxoplasmosis. Moreover,
resistant strains should not be passed through a feline host to prevent the formation of
oocysts having pyrimethamine resistance. Alternative selectable markers such as
expression of cat that mediates CAT resistance (Kim et al., 1993) expression of ble that
mediates bleomycin resistance (Perez et al., 1989) and complementation of tryptophan
auxotrophy using trpB (Sibley et al., 1994) are available, however they exhibit low
transformation frequency as compare to expression of dhfr that mediates pyrimethamine
resistance.

6
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Bleomycin resistance has been used as a selectable marker in T.gondii. ble
resistance gene encodes a small acidic protein BLE which binds to the bleomycin family
of glycopeptide antibiotic with strong affinity (1:1 complex) and prevents toxicity. Tn5
ble from Tn5 transposon (Messina et al., 1995) and Sh ble from Streptoallateichus
hindustanus (Soldati et al., 1995) have been used to express BLE in T.gondii. Bleomycin
provides efficient selection for extracellular tachyzoites, but has minimal effects on
intracellular parasites thus selection is repeated twice to prevent leakiness. Also higher
concentration of the drug can not be used because of its mutagenic effects.
Two non-essential enzymes of nucleotide salvage pathway are also used as
selectable markers for T. gondii transformation (Donald and Roos, 1994). These enzymes
are Hypoxanthine-xanthine-guanine phosphoribosyl trasnferase (HXGPRT) that is
essential for purine salvage and Uracil phosphoribosyl trasnferase (UPRT) that is
important to pyrimidine salvage. HXGPRT has been used to select the transgenic parasite
strains during this study. This enzyme catalyzes the conversion of xanthine to xanthine
monophosphate (XMP), which is then converted to guanine monophosphate (GMP).
XMP can also be synthesized from inosine monophosphate (IMP) by the enzyme IMPdehydrogenase, in the absence of the substrate i.e. xanthine or the enzyme HXGPRT. The
drug mycophenolic acid (MPA) can inhibit IMP-dehydrogenase enzyme and prevents the
conversion of xanthine to XMP and subsequently to GMP.

7
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Figure 1.1
Purine salvage pathway
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Figure 1.1 Purine salvage pathway. This pathway is important for DNA and
RNA synthesis. HXGPRT deleted parasite strain is unable to synthesize GMP from
guanine or hypoxanthine. Selection is made by the drug MPA which inhibits IMPDH
enzyme. Parasites having HXGPRT as selectable marker would be able to synthesize
GMP using xanthine as a substrate.
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HXGPRT deletion mutant (PLKAHX) was used in this study for the generation of
transgenic parasites. When PLKAHX parasites were transformed with the plasmid that
expresses the HXGPRT gene, the selection of transgenic parasites was carried out by
supplementing the medium with MPA and xanthine. Parental strain is unable to use
xanthine as a substrate due to deletion of HXGPRT gene. Other route of xanthine
formation i.e. from IMP to XMP is also blocked due to inhibition of IMP-dehydrogenase
by the drug MPA. On the contrary, transgenic parasites can use xanthine due to the
plasmid insertion that has HXGPRT gene.

1.1.4 Sexual and asexual life cycle of T.gondii
Toxoplasma gondii has the ability to infect and replicate in virtually any nucleated
mammalian or avian cell (Dubey, 1998). T.gondii life cycle is divided into two phases i.e.
sexual and asexual phase. Sexual cycle exclusively occurs in feline intestinal epithelia,
with the cat being a definitive host (Frenkel, 1973). This phase begins when a cat ingests
infected intermediate hosts e.g. rats and birds that have encysted parasites present in their
tissues (Dubey, 1994; Soete et al., 1993). Bradyzoites are released from the cyst in the
small intestine and undergo sexual reproduction. The differentiation of bradyzoites into
micro and macro gametes and later fusion of these gametes results in the formation of
oocyst. The oocyst later develops a thick impermeable cyst wall and excreted in the feces
(Soete et al., 1993). Upon exposure to atmosphere, each oocyst undergoes sporulation
producing eight sporozoites. The mature haploid oocyst is very stable and remains
infectious for months in cold and dry climates (Dubey, 1994).

9
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Figure 1.2
Toxoplasma gondii Life cycle
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Figure 1.2 Asexual cycle occurs in large number of warm blooded animals.
Asexual phase involves two forms of parasite i.e. tachygoites and bradyzoites (1, 2).
Environmental factors especially the host immune response determines the balance
between the two forms: strong immune response results in encystation whereas
reactivation results upon lowered immune response. Transmission within asexual phase
occurs through ingestion of meat infected with encysted bradyzoites (3). Asexual cycle
involves gametogenesis and fertilization in gut epithelium of feline host (4).
Transmission within the sexual phase is by ingestion of oocysts in feaces (5). Crossover
between the two cycles (6, 7) results from accidental ingestion of the mature oocyst or
bradyzoite infected meat.

10
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The asexual life cycle begins with the ingestion of either sporulated oocysts from
cat’s feces or viable tissue cysts in raw or undercooked meat. Ingested cysts are ruptured
as they pass through the digestive tract and results in bradyzoite release. Released
bradyzoites then infect the epithelium of the intestinal lumen and differentiate back to
actively dividing tachyzoite form, enters the macrophages for the dissemination through
out the body, and complete the asexual phase of the life cycle. The immune response
forces the tachyzoites to shift to the encysted bardyzoites that persist for the remaining
life span of the host (Dubey, 1994; Soete et al., 1993).

1.1.4.1 Stages of asexual life cycle
The asexual phase of T.gondii life cycle consists of two distinct stages of growth
i.e. tachyzoite stage or bradyzoite stage. Tachyzoite have an approximate length of 5pm
and width of 2pm (Smith, 1995) and represents rapidly growing form of parasite that is
found during acute phase of toxoplasmosis. The first step of infection is parasite
attachment to the host cell which leads to invasion into parasitophorous vacuole (PV).
Precise origin o f the vacuole is not known yet. However, this invasion process involves
clearing of rhoptries (specialized structure located at the apical end of parasite), and
secretion from dense granules (Carruthers and Sibley, 1997). Unlike many other
Apicomplexan parasites that replicate multiple times before assembly of daughter cells,
toxoplasma replicates by endodyogeny i.e. produce two daughter cells in each division.
In a given vacuole parasites divide synchronously and number of tachyzoites in any
vacuole is always a power of two. With a generation time of 6-8 hours (in vitro)
tachyzoites keep replicating with in the cell until they rupture the host cell to infect
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neighboring cells (Radke and White, 1998). Parasite exit is facilitated by a twisting
motility. Ionic changes in host cell membrane due to mechanical strain from growing
parasitophorous vacuole could induce parasite exit (Endo et al., 1987; Endo and Yatiga,
1990).
Tachyzoites differentiate into bradyzoites that represent slowly dividing form
capable of making tissue cyst and appears 7-10 days after infection. These cysts are
found predominantly in the central nervous system and muscles where they reside for the
life of the host. Formation of tissue cysts throughout the body defines the chronic stage of
asexual life cycle. Bradyzoites can be distinguished from tachyzoites by the difference in
their ultra structure. Bradyzoites accumulates numerous amylopectin granules, have
increased number of micronemes, have electron dense rhoptries and have their nucleus
located posteriorly. Tachyzoites, on the other hand normally lack amylopectin granules,
have fewer micronemes and the nucleus is centrally located (Ferguson and Hutchison
1987; Matsukayashi and Akao 1963; Dubey, 1993). The host-parasite relationship is also
different for both. Tachyzoites proliferates with in a parasitophorous vacuole that has a
single unit membrane and a tubular network is formed from the invaginations of the
membrane into the vacuole. Bradyzoites, on the contrary, develop with in the cyst that is
surrounded by a cyst-wall. The differentiation of tachyzoites to bradyzoites occurs when
the immune system attacks in order to eliminate the proliferating tachyzoites.
Toxoplasma gondii not only modifies its morphology, but presumably its
metabolism also during stage conversion in order to adapt to the environmental changes.
Mechanism of stage conversion between two stages of T. gondii as well as factors
regulating the conversion is not fully understood. Stage specific gene product has been
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used as a marker to understand the kinetics of stage conversion both in vitro and in vivo
models (Burge et al., 1988; Prince et al., 1990; Gazzinelli et al., 1993; Bohne et al 1994;
and Soete et al., 1994). Multiple factors of both host and parasite origin are most likely
responsible for stage conversion. Recent studies have shown that small population of
T.gondii undergoes spontaneous stage conversion in vitro (Tomavo et al., 1991; Soete et
al., 1993). The percentage of bradyzoites in the population can be increased by altering
the pH, adding cytokines such as IFN-y, and treating with mitochondrial inhibitors like
antimycinA (Bohne et al., 1993; Soete et al., 1994). Production of nitric oxide from
activated macrophages has been suggested to induce conversion to bradyzoite in vivo
possibly by interfering with parasite electron transport system (Bohne et al., 1993; 1994).
By altering the parasite mitochondrial function such as energy production, the host tries
to control parasite proliferation. In response to host action, parasite transforms into slow
replicating and less energy-consuming stage to maintain its viability. It is also well
established that high amount of DNA damage can inhibit replication and delay the entry
of cell into mitosis (Nasmyth, 1996). Immunological and environmental stresses involved
in T.gondii differentiation could cause increased DNA damage/repair and result in slow
i

replication of encysted bradyzoites. DNA damage may not be the only reason moreover it
could be the result of nutrient deprivation as a form of stress. Parasites have been
reported to express stage specific proteins e.g. surface antigens or enzymes, which are
probably required for the adaptation (Tomavo et al., 1991; Yang and Parmley, 1995;
Yang and Parmley, 1997; Dzierszinski, 1999). Molecular cloning of the genes encoding
stage specific enzymes is important and could be helpful in investigating the molecular
mechanics involved in T. gondii stage conversion from tachyzoite to bradyzoite.
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1.1.4.2 Stage specific difference in metabolism
Mitochondrial inhibitors such as antimycin A, myxothiazol, and oligomycin have
been reported to increase the expression of bradyzoite-specific antigens indicating a
correlation between mitochondrial function and stage conversion (Bohne et al. 1994;
Tomavo and Boothroyd, 1995). Impaired oxidative phosphorylation due to mitochondrial
dysfunction induces bradyzoite formation in vitro. Key enzymes of TCA cycle and
oxidative phosphorylation have been reported to be missing in bradyzoites (Denton et al.,
1996), while three isoenzymes (lactate dehydrogenase, glucose 6-phosphate isomerase,
and enolase) involved in glycolysis have been reported to express stage specifically
(Yang and Parmley, 1997: Dzierszinski et al., 1999). These observations suggests that
tachyzoites use both mitochondria and glycolytic pathway as ATP generating source,
whereas encysted bradyzoites having impaired mitochondrial oxidative phosphorylation
mainly rely on anaerobic glycolysis (Fulton and Spooner, 1960; Melo et al., 1992;
Vercesi et a l, 1998; Pfefferkom and Borotz, 1994).

1.1.4.3 Stage specific isoenzymes
Lactate dehydrogenase (LDH), Enolase (ENO), Glucose 6-phosphate isomerase
(G6-PI), and phospatidylinositol synthase (PIS) have been reported to express stage
specifically in T.gondii. Except for phospatidylinositol synthase, all are important
enzymes for glycolysis. Stage specific expression of LDH, main focus of the present
study, will be discussed in detail in this section.
Lactate dehydrogenase (L-lactate: oxidoreductase, EC 1.1.1.27) uses NAD+ as a
coenzyme and catalyzes the interconversion of pyruate to lactate during glycolysis. Gene
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encoding tachyzoite LDH has been cloned and named as LDH1 and bradyzoite LDH as
LDH2. These two LDH genes show 64% nucleotide identity in their coding region and
both have an intron at the same relative position. Size of the intron is 538nt and 588nt in
LDH1 and LDH2 respectively. Amino acid sequences of the two LDH proteins share
71.1% identity. Using RT-PCR, Yang and Parmley (1997) have demonstrated that
mRNA of LDH1 is found equally in both stages of the T. gondii while mRNA of LDH2
is only detected in bradyzoite stage. The absence of LDH2 mRNA in tachyzoites suggests
that LDH2 transcription is suppressed during transition from bradyzoite to tachyzoites.
These data also suggest that LDH1 is exclusively expressed in tachyzoites.

LDH2

mRNA levels have been reported to increases predominantly when tachyzoite to
bradyzoite differentiation is induced. LDH2 mRNA stability was not determined during
the study, thus it is not clear whether this increament in LDH2 mRNA is due to
transcriptional activation of the LDH2 gene or an increase in mRNA stability.
Yang and Parmley (1997) also demonstrated that LDH1 enzyme is only
detectable in tachyzoites using two dimensional PAGE. Difference in isoelectric points
i.e. 5.96 for LDH1 and 7.08 for LDH2 has been exploited to show that only one LDH
protein is expressed in each stage. The possibility of higher isoelectric point of bradyzoite
LDH due to tyrosoine phosphorylation was ruled out as it would only make tachyzoite
LDH more acidic (Cooper et al., 1983). Post-translational modifications that make LDH
more basic have not been reported yet. These results suggest that two distinct forms of
LDH proteins are produced in each stage i.e. LDH1 in tachyzoite stage and LDH2 in
bradyzoite stage. Putative promoter sequences of respective LDHs have been used to
express CAT reporter construct. Approximately 1500 nt upstream and downstream
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sequence of LDH1 were used for CAT expression. High CAT activity observed in
tachyzoites was reduced to four fold when parasites were switched to bradyzoite stage.
Similarly 993 nt upstream and 1750 nt downstream sequence of LDH2 were used for
CAT expression. No activity was detected during tachyzoite stage while CAT expression
was increased to forty five fold with the differentiation to bradyzoites. This indicates that
the production of LDH2 seems to be under transcriptional control due to the appearance
of LDH2 mRNA only in bradyzoites, while production of LDH1 appears to be under
translational control as mRNA of LDH 1 is present in both stages but it is translated only
in tachyzoites. Roos et al., 1997 has also showed that putative LDH2 promoter sequences
are involved in stage specific LDH2 expression during bradyzoite differentiation. Using
cNTPase (Nucleotide triphosphatase lacking N-terminal signal) as a reporter they
demonstrated that the reporter expression is transcriptionally controlled with the stage
conversion. In conclusion, the process of developmental regulation of the two LDH genes
appears to be different for each stage. Studies have shown that LDH1 and LDH2 genes
are found on different chromosomes i.e. LDH1 on chromosome VIII and LDH2 on
chromosome IX. When the expression of both the LDHs was knocked down using
dsRNA, growth rate in both the stages varied as compared to parental strain and parasite
differentiation (in-vitro) was impaired. Tachyzoites were unable to form significant
number of cysts in vivo, to establish a chronic infection (Fatme Al-Anouti et al., 2004).
These results indicate that LDH expression is important for T.gondii cell cycle.
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1.2 Eukaryotic gene regulation
Eukaryotic gene expression is primarily controlled at the level o f transcription
initiation (Lemon and Tijan, 2000). Housekeeping genes are expressed constitutively and
are shut down in response to extreme environmental condition such as heat shock or
starvation (Prikkala et al., 2001). Facultative genes, on the contrary are expressed in
response to specific physiological, hormonal or environmental stimuli (Benecke et al.,
2001). Eukaryotic genes that code for protein are transcribed by RNA polymerase II
hcloenzyme which is composed of 10-12 proteins (Lee and Young, 2000). All the genes
that are transcribed by the RNA polymerase have two core promoter elements, the TATA
box and the initiator sequence. Promoters can not generate significant level of mRNA by
itself, they determine transcription start site and initiate low or basal level of transcription
(Kuras and Struhl, 1999). Transcriptional machinery assembles on the promoter which
serves as a docking site for the transcriptional complex. Most of the proteins that bind to
basal promoters are ubiquitously expressed and have little regulatory specificity (Lemon
and Tijan, 2000). These proteins are called general transcription factors. In addition to the
promoter, some regulatory sequences are also needed for accurate regulation of
transcription and are usually located upstream of the promoter sequence. For example,
the consensus sequences of two regulatory elements CCAAT and GGGCGG (called GC
box) are located 100 base pair upstream of the TATA box. These regulatory sequences
are found in many eukaryotic genes and were first identified during the promoter studies
of the gene encoding thymidine kinase in herpes simplex virus. Some regulatory
sequences known as enhancers are located far from the promoter (could be 10 kbp away)
and were first described by Walter Schaffner in 1981, during the studies of promoter of
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another virus SV40. Activity of enhancer is independent of distance or orientation
(Blackwood and Kadonaga, 1998). On the contrary, upstream repressor sequences have
been reported to inhibit transcription when bound to specific factors (Hanna-Rose and
Hansen, 1996). Inhibition occurs through various mechanisms such as interference in
activator binding or modification in chromatin structure. The silencer, on the other hand,
is the DNA sequence that represses promoter activity regardless of its orientation and
position (Guarente, 1999). In higher eukaryotes a CpG dinucleotide motif is reported to
be involved in gene silencing through DNA methylation (Antequera and Bird, 1999).

1.2.1 Regulation of transcription by chromatin structure
Eukaryotes maintain and control their huge genetic content by packing DNA into
nucleosomes (Luger et al., 1974). Packaging of promoter into chromatin is a key
determinant in transcription initiation (Grunstein, 1997). Studies have shown that
transcriptional activators are associated with histone acetyl transferase (Wolffe and Pruss,
1996) while transcriptional repressors are linked with histone deacetylase (Pazin and
Kadonaga, 1997). Protein complexes named as nucleosome remodeling factors facilitate
the binding of transcription factors to the DNA. By catalyzing the histone octamer along
the DNA, they reposition the nucleosome and help binding of transcription factors to the
DNA. DNA methylation at cytosine residues that precedes Guanine (CpG dinucleotide) is
associated with reduced transcription. A protein MeCP2 binds to methylated DNA and
represses transcription (Geoffrey MC, 2000).
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1.2.2 Post-transcriptional gene regulation
RNA processing involves addition of 5 'cap, addition of 3 'polyA tail and removal
of introns and represents another level of gene regulation. The sequence AUUUA in
3'UTR is the signal for early degradation and short lifetime of mRNA. The higher the
frequency o f occurrence of this sequence, the shorter the life span of mRNA. Since the
lifespan is encoded in nucleotide sequence, it is different for each mRNA and can not be
varied. Information about the life span and stability of RNA is found in 3 'UTR
(untranslated region) of gene. 3'UTR have been reported to affect gene expression by
modulating RNA stability and translation (Casey et al., 1988 and Hentze et al., 1988).
Role of 3 'UTR in suppression of basal and growth-hormone induced transcription has
also been reported (Le Cam and Legraverend, 1995). UTRs of other genes have been
reported to function as regulatory elements of the genes and affect transcription
efficiency. Expression of human aggrecan gene has been reported to depend on the
sequence present in 5'UTR (Wilmot et al., 1998) which is thought to serve as the binding
site for general transcription factors that are needed for the assembly of transcription
initiation complex. On the contrary, erythropoietin gene expression was reported to be
enhanced upon removal of 5' and 3' UTRs (Park et al., 2001).

1.2.3 Translational gene regulation
Factors affecting mRNA translation includes m7G cap, length of 5 'UTR, position
and context of initiator codon (AUG), and high order structure within mRNA (Nicola and
Matthias, 1994). Structural elements in mRNA control translation initiation. Stability and
position of secondary structure introduced into the 5 'UTR of mRNA has been reported to
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inhibit its translation (Lawson et al., 1986). When a secondary structure 12 nucleotide
away from the m7G cap was introduced into mRNA, it strongly diminishes translation in
vitro. Same structure, when placed 52 nucleotide downstream of the m7G cap, had no
effect on translation. It is suggested that when the distance between the m7G cap and
secondary structure was sufficient enough to allow 43 S entry, progression of 43 S pre
initiation complex and associated factors occurred which disrupted the secondary
structure and resulted in translation (Lawson et al., 1986). Various cellular mRNAs that
code for transcription factors or growth factors have unusually long 5UTRs with
upstream AUG, small ORF and strong secondary structures that result in poor translation
(Kozak, 1991). For example mRNA of human platelet-derived growth factor-2 (PDGF2)
has 5'UTR of 1022 nucleotides with 140 nucleotide GC-rich regions. GC-rich region
immediately preceding AUG was found to be responsible for the poor translation of
PDGF2. Role of secondary structure in 3UTR in regulation mRNA translation has not
been established. However, long range interaction between 5 'UTR and 3 'UTR has been
reported to regulate mRNA translation in Zea mays (Spena and Dobberstein, 1985).
Secondary structure in various mRNAs serve as binding sites for repressor protein
and provides translational suppression and rapid regulation of gene/mRNA in response to
cellular or extracellular stimuli. For example expression of ferritin (an iron storage
protein) is regulated at translational level. Regions in the 5'UTR termed as iron
responsive element (IRE) were capable of forming stem-loop structure and sufficient to
control translation of ferritin mRNA in response to cellular iron concentration. (Hentze et
al., 1987; Hentze et al., 1988). IRE is a highly conserved stem-loop structure which is
important in mediating translational control in vivo and in vitro (Gray et al., 1993). A
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similar translational regulation has been identified in haem synthesis enzyme, erythroid
5-aminolevulinic acid synthase (eALAS). An IRE was found in 5'UTR of eALAS
mRNA to regulate the translation (Melefors et al., 1993). Multiple IRE have been
reported in 3UTR of mRNA encoding transferrin receptor (involved in iron uptake in
cell). However, translation is controlled here via change in mRNA stability (Klausner et
al., 1993). Human thymidylate synthase (TS) mRNA has been shown to undergo
translational autoregulation in vitro (Chu et al., 1993). A 29 nucleotide stem-loop motif
in 5UTR of the mRNA, specifically interact with TS protein. Similarly human
dihydrofolate reductase mRNA translation is also autoregulated. Role of RNA elements
in such translational regulation is to provide access sites for repressor protein. Ribosomal
protein synthesis is translationally regulated in Saccaromyces cerevisiae, Xenopus laevis,
and mammalian cells. These mRNAs contain short 5'UTR (35-50 nucleotides), have a
polypyrimidine tract (8-14 nucleotide) in cap-proximal position. 5 'UTR of Xenopus
laevis S19 and murine S16/L30 mRNA are sufficient for regulation of translation. The
polypyrimidine tract is necessary but has not been reported to be sufficient alone (Levy et
a l, 1991).
Elements in 3UTR which serve as protein binding site can also regulate mRNA
translation by mediating changes in poly-A tail length. Erythroide lipoxygenase LOX
mRNA is expressed at early stage and must be translationally silenced in immature
erythroide cells. 3'UTR (576 nucleotide) of rabbit (LOX) mRNA has ten repeats of 19
nucleotide pyrimidine

rich element and starts 50 nucleotide down stream from the

translation termination codon (Fleming et al., 1989). Human reticulocyte LOX mRNA
has four such repeats and sufficient for regulation. These pyrimidine repeats specifically
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interact with LOX-BP protein (48kDa) which represses LOX mRNA translation. UA-rich
sequences in 3'UTR (associated with mRNA instability) also serve as binding site for
repressor proteins and regulate translation of tumor necrosis factor mRNA translation
(Goodwin et al., 1993).

Objectives
From the previous studies it has been established that mRNA of LDH 1 is present in both
stages of asexual life cycle of T.gondii i.e. rapidly replicating tachyzoites and encysted
bradyzoites. However, LDH1 protein is expressed only in tachyzoites but not in
bradyzoites, suggesting a post-transcriptional and/or a translational suppression of LDH 1
in bradyzoites. On the other hand LDH2 mRNA is present only in bradyzoites and is
translated to LDH2 protein, showing a transcriptional regulation of the LDH2 gene (Yang
and Parmley, 1997). Governing mechanism involved in distinct expression of two LDHs
i.e. LDH1 in tachyzoites and LDH2 in bradyzoites, is still unclear. Putative promoter and
downstream sequence of LDHs have been reported to play a role in differential
expression of LDHs during parasite stage conversion (Yang and Parmley 1997;
Boothroyd et al., 1997). The study was divided into two parts, using plasmid
pTub 8 mycHisGFP-HX as control in both parts of the study.
1. To refine the search for the putative promoter and downstream sequence for LDH1 and
create a tool for the long term goal, using GFP reporter system, followings were the
objectives.
a)

To construct three different plasmids from the control and to generate four

transgenic parasite strains from these plasmids. In transgenic control strain GFP reporter
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expression is under TUB8 promoter with a 3UTR of SAG1 downstream GFP. Among the
three test transgenic strains, one strain has upstream sequence of LDH1 alone, other strain
has both upstream and downstream sequence of LDH1, and the last strain has
downstream region of LDH1 alone, such that the first two strains are under the control of
putative LD H promoter and the last strain is under TUB8 promoter control.
b) To determine GFP levels and its localization in both stages of T.gondii to
establish the role of upstream and downstream sequence of LDH1 in translational
suppression.
2. To create tools for the long term goal for the understanding of the mechanism behind
transcriptional regulation of LDH2,
a) To generate two transgenic parasite lines using mycLDH1 and mycLDH2 as
reporter, from the same control plasmid i.e. reporter expression is under the influence of
Tub 8 promoter and has 3'UTR of SAG1 downstream of the reporter.
b) To determine the levels of constitutive mycLDHl/LDH2 expression by western
blot.
c) To monitor the effect of LDH misregulation on the phenotype of the both
stages of the parasite.
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CHAPTER 2
MATERIALS AND METHODS

2.1 Parasite strain and chemical supplies.
PLKAHX strain, used in this study was obtained from the AIDS Research and
Reference Reagent Program, NIH. The T.gondii strain PLKAHX was derived from the
slowly multiplying strain PLK. The gene encoding hypoxanthine-xanthine-guanine
phosphoribosyltransferase has been silenced in the PLKAHX strain. This silencing allows
the selection of the transgenic parasites (Donald and Roos, 1995; Donald et al., 1996).
Following is the list of chemicals and reagents used in this study along with the
name o f the supplier:
Amersham-Pharmacia Biotech (Baie d’Urfe, Quebec)
2' -deoxyribonucleoside 5'-triphosphate (dNTPs), nitrocellulose membranes.
Baxter Diagnostics Corp. (Toronto, ON)
Nalgene™ disposable 25mm syringe filters (0.2 pm pore size) and glass Pasteur pipettes.
Bio-Rad Laboratories (Mississauga, ON)
Bromophenol Blue, Coomassie brilliant blue R-250, Xyelene Cyanol, protein molecular
weight standards (medium range), and protein assay dye reagents.
Carolina Biological Inc
Restriction enzyme BamHI
Gelman Sciences (Ann Arbor, MI)
The Vacucap™ disposable bottle-top filter for sterilization of media.
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GibcoBRL Invitrogen (Burlington, ON)
Cell culture media Dulbeco’s modified essential medium (DMEM), minimal essential
medium (MEM), Dulbeco’s phosphate buffered saline (DPBS) supplemented with
calcium, trypsin, penicillin-streptomycin (10 pg/ml), L-glutamine.
Hyclone (Logan, UT)
10%

cosmic calf serum.

Invitrogen Corporation (Burlington, ON)
Proteinase K, Trizol reagent, and RNase out ribonuclease inhibitor.
NewEngland Biolabs Inc
Restriction enzymes Kpnl, Nsil, Pstl.
Promega (Madison, WI)
Agarose, Mung Bean Nuclease, T4 DNA ligase, Moloney murine leukemia virus reverse
transcriptase (M-MLV), RQ1 RNase free DNase, DNA ladder lkb and 100 bp, Multicore
buffer, EcoRI, Hindlll.
Qiagen (Mississauga, ON)
QIAEX® I and plasmid midi prep kits for DNA purification.
Roche Diagnostics (Laval, Quebec)
Taq DNA polymerase.
Sigma-Aldrich (Oakville, ON)
Acetic acid, ampicillin, tetracycline, chloroform, 4 ',6 diamidino-2-phenylindole (DAPI),
Dolichos biflorus conjugated to fluorescein isothiocyanate, dimethylsulfoxide (DMSO),
dithiothreitol (DTT), diethylpolycarbonate (DEPC), ethanol, agar, ethidium bromide,
formaldehyde, glycine, glycerol, hydrochloric acid, mycophenolic acid (MPA),
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polyoxyethylene sorbitan monolaurate (Tween-20), 2-propanol, phenyl methyl sulfonyl
fluoride

(PMSF),

sodium

citrate,

sodium

chloride,

sodium

acetate,

tris

hy dromethyl aminomethane (Tris), Triton X-100, Trichloroacetic acid, Xanthine, midiprep plasmid purification kit.
Stratagene (La Jolla, CA)
XL1BL bacterial strain.
TaKara Bio Inc
Restriction enzyme HincII
USB (Cleveland, OH)
Acrylamide, bis-acrylamide, ammonium persulfate (APS), equilibirated phenol, RNaseA,
Sodium dodecyl sulphate (SDS)
Nucleopore (ON)
Polycarbonate filters (3 pm pore size)
Wisent (Montreal)
Dialyzed fetal bovine serum (FBS)
pTUB 8 mycHisGFP-HX plasmid (kindly donated by Dr. Dominique Soldati)

2.2 Apparatus and Instrumentation
Miniature Horizontal Gel System MLB-06 from Tyler Research Instruments was
used for DNA agarose gel electrophoresis. Gels were viewed and images were captured
using Alphalmager™ 2200 Light Imaging system with AlphaEase software. Vertical gel
electrophoresis system, including all glasses, Teflon combs and spacers from BRL
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(Bethesda Research Laboratories) were used to run Sodium dodecyl sulphate-poly
acrylamide gel electrophoresis (SDS-PAGE).
J2-HS centrifuge (Beckman), desktop Eppendorf Model 5415C microcentrifuge
from Desaga (Sarstedt Gruppe, Germany) or BR4i Centrifuge (Jouan, SA) were used to
carry out centrifugations.
Protein quantification was performed using Shimadzu UV-Visible Recording
spectrophotometer, Hadley Tekscience.
Polymerase chain reaction (PCR) was carried out using 20-well Techgene
Thermal Cycler (Techgene. Cambridge, UK). Ligation reactions were performed in 48well Perkin Elmer Cetus DNA thermal Cycler (Perkin Elmer. Norwalk, CT).
Cell and parasite cultures were conducted in the class II type A/B3 Biosafety
cabinet (Jouan, SA). All cultures were maintained in a CO2 incubator (Thermoforma).
Electroporations were performed using BTX model; 600 Electro Cell Manipulator
(Genetronics). All Bacterial cultures were grown in NEW BRUNSWICK SCIENTIFIS
G-25R shaking incubator.
All glassware, broth solutions were autoclaved prior to use in order to maintain
sterile conditions throughout bacterial culturing.

2.3 General methods
2.3.1 Agarose gel electrophoresis
Miniature Horizontal Gel System MLB-06 (Tyler Research Instruments,
Edmonton) was used for agarose gel electrophoresis. 1% (w/v) Agarose gel was made by
dissolving solid agarose in Tris-acetate EDTA (TAE) buffer, 40 mM Tris-acetate, ImM
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EDTA. Ethidium bromide was later added to a final concentration of lOng/ml. The gel
was first allowed to solidify in the electrophoresis tray and than immersed into the
electrophoresis tank filled with lx TAE buffer. DNA samples were mixed with the gel
loading buffer (0.025% Bromophenol blue, 0.025% Xyelene Cyanol FF, lOmM EDTA
pH 8.0 and 98% deionized formamide) and were loaded into the wells. DNA marker was
loaded and the gel was electrophoresed for 30-45 min at 100V (Sambrook 1989). The
gels were visualized using Benchtop Ultraviolet Transillumoinator (YWR Scientific.
Mississauga, ON). Alphalmager 2200 Light Imaging System with AlphaEase Software
was used to capture gel images and for the photography of ethidium bromide stained
agarose gels (Alpha Innotech Corporation, San Leandro).

2.3.2 Reverse Transcription (RT)
Reverse transcription reaction was carried out by mixing 2pg of extracted RNA
with 50 pico moles of oligo dT. This was incubated at 70°C for 5 minutes to remove
RNA secondary structure and then chilled on ice for 1 minute. The mixture was
completed to 10 pi by adding in order, 2pl of M-MLV reverse transcriptase 5 x buffer,
1.5pl of dNTPs (2.5 mM), 0.5pl of RNaseOut (40 U/pl), lp l of M-MLV reverse
transcriptase (50U/pl) and incubated for 1 hr at 37°C. Reverse transcriptase was then heat
inactivated at 95°C for 5 minutes. 4pl of the RT-mixture was used as a template for
subsequent PCR amplification. Any genomic DNA contamination was checked by
running a PCR using ROP1 primer. No PCR amplification indicated that RNA sample is
un-contamination.
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2.3.3 Polymerase Chain Reaction (PCR)
Polymerase chain reaction (PCR) was performed using 20-well Techgene thermal
cycler (Techne, Cambridge, UK). The PCR was performed in a total volume of 50pl
containing 75mM Tris-HCl pH 8 .8 , 50 mM KC1, 2mM MgCl2, 50 mM dNTPs, 2 U of
Taq DNA polymerase and 0.5 pi of oliginucleotide primers (100 pmol/pl). The
amplification reaction included 35 cycles each consisting of denaturation at 94°C for 30
sec, annealing at 55°C for 30 sec, and extension at 72°C for 45sec. lp l of genomic DNA,
as a positive control and autoclaved water, as a negative control were used as templates in
the amplification reaction. Amplified product was resolved in a 1% (w/v) agarose gel.

2.3.4 Host cell culture
Human foreskin fibroblasts (HFF; obtained from Dr.Roos, University of
Pennsylvania) were used as a host for the intracellular parasite T.gondii. These HFF cells
were grown as a monolayer in Dulbecco’s Modified Eagle Medium (DMEM)
supplemented with 5ug/ml streptomycin, 5units/ml penicillin and 10% cosmic calf serum,
in a 5% C 0 2 atmosphere.
To propagate the host cells, confluent HFF cultures were detached by adding 1 ml
of Trypsin EDTA solution (0.25% trypsin, 0.3%EDTA) followed by incubation at 37°C
for 45 seconds. Detached cells were suspended in fresh media and split into 3-4x the area
of old culture.
To freeze the host cells for later use, cells were pelleted after trypsin treatment.
These pellets were resuspended in cell freezing medium containing 25% dimethyl
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sulfoxide (DMSO) and 20% dFBS (dialysed fetal bovine serum) in DMEM and were
immediately placed in cryovials and were stored at -80°C.

2.3.5 Toxoplasma gondii Culture
Toxoplasma gondii was propagated in HFF grown in MEM medium with Lglutamine, supplemented with 1% dialyzed fetal bovine serum. Parasites scraped from
infected HFF monolayers were used to infect a new monolayer of HFF grown in MEM
medium (Donald and Roos, 1994).

2.3.6 Parasite Pelleting
Freshly released tachyzoites from HFF monolayer were scraped, passed through a
27 G-l/2 syringe needle to release parasites from vacuole, filtered through a 3pm
polycarbonate filter to remove all the host cell debris, and than pelleted by centrifugation
at 2000-3000 rpm for ten minutes. Parasite pellet were stored at -80°C for later use for
genomic DNA, RNA or protein isolation.

2.3.7 Genomic DNA Isolation
Genomic DNA was extracted by resuspending the parasite pellet in 0.2 ml lysis
buffer (ImM EDTA, lOmM Tris pH 8.0, 0.5% SDS, 0.2pg/pl Proteinase K, 0.125pg/pl
RNase) followed by incubation at 56° C for 4-6 hrs. The suspension was extracted twice
with 0.2 ml of phenol: chloroform: isoamyl alcohol and once with chloroform. Genomic
DNA was then recovered from the aqueous phase and precipitated with 0.1 volume 3M
sodium acetate and 2.2 volume 95% ethanol followed by centrifugation at 7500 rpm for
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10 min. Genomic DNA pellet was washed using 70% ethanol and dried followed by
resuspension in 2 0 pl autoclave water.

2.3.8 RNA extraction from T.gondii
Parasite pellet was lysed with 500pl Triziol reagent and incubated for 5 min at
room temperature to permit a complete dissociation of nucleoprotein complexes. lOOpl of
chloroform was added to the mixture and was shaken vigorously for 15 seconds and
incubated at room temperature for 2 min. Phase separation was carried out by
centrifugation at 12000 rmp at 4°C for 15 minutes. The upper aqueous layer containing
RNA was precipitated by 250pl of isopropyl alcohol and incubated at room temperature
for 10 minutes and then centrifuged at 10000 rpm for 10 minutes at 4°C. Precipitated
RNA was washed with 500pl of 70% ethanol and resuspended in DEPC-treated water.
Any genomic DNA contamination was removed by treating the RNA with 4 units of RQ1
RNase-free DNase for 20 minutes at 37°C. DNase was subsequently inactivated by
heating at 75°C for 5 minutes.

2.3.9 Protein quantification by Bradford Assay
Bradford assay was used to determine protein concentration using the Agilent
UV-visible spectrophotometer (Shimadzu). Parasite pellets were completely resuspended
in 200 pi of lysis buffer (HEPES 50pM, PMSF 5pM, Triton X I00 0.025%, Glycerol
20%) and centrifuged at 13000 rpm for 10 min and the supernatant having protein in it,
was collected in a separate tube. The protein sample was mixed with 0.7 ml of working
Bradford reagent and incubated for 10 min at room temperature. Using the Bradford
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reagent as blank, spectrophotometric measurements were carried out at 595 n.m. A
standard curve made from standard protein solution of BSA was used to determine the
concentration of the unknown protein in the test samples (Sambrook 1989).

2.3.10 Sodium dodecyl sulphate-Polyacrylamide gel electrophoresis
A discontinuous buffer system was used to conduct sodium dodecyl sulphatepolyacrylamide gel electrophoresis (SDS-PAGE) (Laemmli, 1970). The stacking and
resolving gels were caste in a vertical gel electrophoresis system from BRL (Bethesda
Research Laboratories). The resolving solution was poured first and left to polymerize,
then stacking gel was overlaid on to it. Samples were mixed with the gel loading buffer
(Appendix) and boiled for 5 min, centrifuged at 13000 rpm for 30 sec and then loaded
into the wells. The gel was run with Tris-Glycine running buffer (25mM Tris, 192 mM
Glycine and 1%SDS) at 130 volts until the bromophenol dye came out of the gel.

2.3.11 Electro-blotting and immunodetection
The proteins were transferred to nitrocellulose membrane at 130 mA for 2 hrs, in
the transfer buffer (20mM Tris pH8.0, 150mM Glycine and 20% methanol) using electroblotting (BIO-RAD) apparatus. The blot was incubated with the blocking buffer (5%
non-fat dry milk in TBS) for 1 hr at room temperature on a shaker, followed by one wash
with TBS buffer. The blot was then incubated with the primary antibody solution
(GFP/LDHl/His antiserum, diluted to 1:500 in 2.5% non-fat dry milk in TBS) for over
night on a shaker at 4°C. Blot was washed 3x5 minutes with TBST (TBS containing 0.1%
Tween20) and incubated with anti-rabbit/goat IgG-HRP conjugate (diluted 1:10,000 in
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2.5% non-fat dry milk in TBS) for 1 hr at room temperature on a shaker. Finally, the blot
was washed twice with TBST and the product was revealed using ChemiGlow West
detection kit (Alpha Innotech).

2.3.12 Immunofluorescence assay
Host cells, HFF, were grown as monolayer in a culture plate with glass cover
slips. Using the selection medium, these monolayers were infected with the following
parasite strains i.e. negative control (PLKAHX), transgenic control (mycHisGFP-HX)
and the three test strains (5'UTRGFP-HX, 3 '5 'UTRGFP-HX, 3'UTRGFP-HX), and
allowed to grow for 4-5 days. After aspirating off the culture media, the cells were
washed thrice with Dulbeco’s phosphate buffered saline (DPBS) and were fixed with 3%
paraformaldehyde in phosphate buffered saline (PBS) for 10 minutes. Cells were
permeabilized with 0.25% Triton X-100 in PBS for 10 minutes. After washing twice with
PBS, the cells were blocked with 5% Bovine serum albumin (BSA) in PBS for an hour at
room temperature (Yahiaoui et al., 1999). Cover slips were then incubated with the
primary antibody (Goat GFP anti-serum diluted 1:200 Rockland Inc Gilbertsville, PA) in
a humidity chamber for 2 hrs at room temperature. After three washes with PBS, cells
were incubated with rabbit anti-goat IgG conjugated to rhodamine (diluted 1:300,
Rockland Inc Gilbertsville, PA) in a dark humidity chamber for 1 hour and washed with
the PBS again. For cyst staining, cells were incubated with Dolichos biflorus agglutinin
conjugated to FITC (diluted 1:300, Sigma) for 1 hour. Cellular nuclei were stained by
incubating the cells for 10 minutes with 4',

6

diamidino-2-phenylindole (DAPI, Sigma),

followed by three washes with PBS. Cover slips were placed carefully on the glass slides
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and were allowed to dry and finally overlaid with fluoromount and examined with a
Leica DMIRB microscope. All images were taken with a cooled Q-Imaging CCD camera
using Improvision Openlab software.

2.4 Plasmid construction and purification
For genetic studies in T. gondii, electroporation is the most efficient means of
transformation. Parent plasmid pTUB 8 mycHis GFPHX (6418-bp) has GFP as a reporter
gene. The sequence and map of this plasmid can be found in Appendix A. It has 3 'UTR
(untranslated region) of SAG1 (surface antigen) downstream GFP. Under the control of
tubulin promoter it can produce GFP fused to Myc and 6 xHis tags at the N-terminus. This
plasmid carries an ampicillin resistant gene for bacterial selection and an expression
cassette of hypoxanthine-xanthine-guanine phosphoribosyltransferase (HX) that allows
the selection of stably transformed parasites when media is supplemented with the drug
mycophenolic acid and xanthine as a substrate. Parent plasmid pTUB 8 mycHisGFP-HX
was used to generate two sets of plasmids.

2.4.1 Construction of plasmid with GFP reporter gene
To investigate the role of 5'UTR and 3'UTR of LDH 1 (lactate dehydrogenase) or
either one of them, in translational suppression of LDH 1 enzyme during bradyzoite stage,
the parent plasmid was modified to produce three different plasmids as follows,
1.

For the investigation of the role of 5 'UTR of LDH 1 alone, Tub

8

promoter was

replaced by upstream sequence of LDH1 (626-bp) and the plasmid was named
p5'UTRL1GFP-HX. This plasmid still has 3'UTR of SAG1 downstream GFP. The
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sequence and map of this plasmid can be found in Appendix A. The parent plasmid was
digested by Kpnl and EcoRI to remove the Tub8 promoter (495-bp) from the parent
plasmid and then gel purified. EcoRI site was made blunt by treating with mung bean
nuclease. In order to remove 5 TO 4 group from the linearized plasmid, it was treated with
alkaline phosphatase to help in later ligation reaction. Again using genomic DNA as a
template, the upstream region of LDH 1 (626-bp) was amplified, and extracted from the
gel as mentioned above. Kpnl and Hindlll restriction sites were introduced using specific
nucleotide primers named as Hindlll dws 600 LDH1 and Kpnl ups 600 LDH1
respectively. The sequences of the primers are listed in Appendix A. Phosphorylation of
the insert was done to help in ligation. Hindlll site was made blunt by mung bean
treatment. Phenol chloroform extraction and ethanol precipitation was done. This insert
was ligated into the resulting plasmid p5UTRLlGFP-HX. Parasite strain generated from
this plasmid was 5UTRGFP-HX
2.

For the investigation of the role of 3'UTR of LDH 1 alone, 3'UTR of SAG1

was replaced by downstream sequence of LDH1 and the plasmid was named
p3'UTRLlGFP-HX. This plasmid is still under the influence of Tub8 promoter. The
sequence and map of this plasmid can be found in Appendix A. The insert, downstream
sequence of LDH1 (794-bp), was made by PCR from genomic DNA. PacI and BamHI
restriction sites were introduced by specific nucleotide primers named BamHI 3UTR dws
78LDH1 and PacI 3UTR ups 780 LDH1. The sequences of the primers are listed in
Appendix A. Restriction sites were introduced for later sticky end ligation reaction. PCR
product was run on gel and 794-bp band was excised from the gel and purified using
QIAEX®II Gel Extraction kit from QIAGEN. Parent plasmid was digested with BamHI
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and PacI enzymes. 3 'UTR of SAG1 (320-bp) was removed from the parent plasmid. The
digested plasmid was run on gel, and 6098-bp band was excised and gel purified as
described above. Using purified plasmid, 794-bp insert was ligated in. This plasmid was
named p3UTRLlGFP-HX. Parasite strain generated from this plasmid was 3UTRGFPHX.
3.

For the investigation of the role of both 3 'and 5'UTR of LDH1, 3'UTR of

SAG1 from plasmid 5'UTRGFP-HX was replaced by the downstream sequence of LDH 1
and named p3'5'UTRLlGFP-HX. Using p3'UTRLlGFP-HX plasmid, Tub 8 promoter
(495-bp) was digested and removed using Kpnl and EcoRI enzymes. EcoRI site was
made blunt and the insert was ligated as described above. Parasite strain generated from
this plasmid was 35UTRGFP-HX. The sequence and the map of this plasmid can be
found in Appendix A.
Parent plasmid pTUB 8 mycHisGFP-HX served as a positive control. Gene bank accession
numbers for LDH1 and LDH2 mRNA are U35118 and U23207 respectively.

2.4.2 Construction of plasmid with mycLDHl/LDH2 reporter gene
Using the same parent plasmid i.e. pTUB 8 mycHisGFP-HX, another set of
plasmid was generated to investigate that if the above hypothesis is true (3 'and 5 'UTR of
LDH1 do play a role in translational suppression) then a) can the removal of suppression
(3'and 5'UTR of LDH 1) in bradyzoites result in continuous LDH1 expression and b) can
the overexpression o f LDH2 in tachyzoites force encystation. Two following plasmids
were generated from the same parent plasmid.
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1. Genomic DNA from T.gondii was used as a template for reverse transcription
reaction to get complementary DNA (cDNA) and then PCR was done to amplify open
reading frame (ORF) of LDH1 (990-bp). Specific primers were used to introduce Nsil
and PacI sites and named as 3LDH PacI and 5LDHx Nsil respectively. Specific
sequences

of the primers

are

listed in Appendix A.

The parent plasmid,

pTUB 8 mycHisGFP-HX was digested with Nsil and PacI enzymes and GFP was
removed. ORF o f LDH 1 was ligated in the plasmid by sticky end ligation. In this plasmid
GFP reporter was replaced with open reading frame of LDH 1 enzyme and the plasmid
was named pmycLDHl-HX. The parasite strain generated from this plasmid was
mycLDHl-HX.
2.

The second plasmid was made in a similar fashion as the one described above.

In this plasmid, however, ORF of LDH2 (982-bp) was ligated in the plasmid at Nsil and
PacI sites. GFP reporter was replaced with open reading frame of LDH2 enzyme and the
plasmid was named pmycLDH2-HX. The sequence and the map of this plasmid are listed
in Appendix A. The parasite strain generated from this plasmid was mycLDH2-HX.
Both of these plasmids are under the control of Tub8 promoter, have ten amino acid myctag,

8

x His tag, ampicillin resistance, and HX as selectable marker. The parent plasmid

pTUB 8 mycHisGFP-HX served as a positive control again in this set of experiment.

2.5 Plasmid transformation into E.coli
2.5.1 Preparation of competent bacteria
XLiBL E.Coli cells were grown on agar plate containing tetracycline (0.1g/l). A
single colony was picked from the plate & inoculated into 5mls of LB with tetracycline
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and incubated overnight in the shaker incubator at 37 °C. Next day it was transferred to
500 ml LB and incubated for 3 hrs of vigorous shaking. The bacteria were then chilled in
ice for 15 min and then pelleted at 5000 rpm for 15 min at 4°C. Pellet was resusupended
in 100 ml of Cold sterile CaC^ (lOOmM) and then centrifuged again at 5000 rpm for 15
min at 4°C. The pellet was washed three times with 50ml of CaCL solution and
centrifuged as described. Finally the pellet was resuspended in 200mM CaCL and 25%
glycerol and then aliquoted into microfuge tubes and stored at -80°C for later use
(Sambrook, 1989).

2.5.2 Transformation of competent bacteria
5pl o f the ligation reaction product was mixed with 25 pi of freshly thawed
competent E. Coli cells and incubated on ice for 20 min. The cell suspension was heatshocked for 45 sec at 42°C and incubated on ice for another 2min. 400pl of LB broth was
added to the cells and incubated for 30 min at 37°C with shaking. Cells were centrifuged
at 1000 rpm for 30-45 sec. 300pl of supernatant was discarded and the remaining lOOpl
was used to spread on LB agar plate containing 0.1 g/1 ampicillin. Plates were then
incubated for overnight at 37°C (Sambrook, 1989).

2.5.3 Plasmid isolation from transformed bacteria
After the positive clones were identified, recombinant plasmids from transformed
bacteria were isolated by plasmid mini-preparations (Sambrook, 1989). Confirmation of
ligation was done by restriction mapping. Large scale plasmid preparation was performed
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using Gen Elute™ HP Plasmid Midiprep kit from sigma for later electroporation of
plasmid into the parasites.

2.6 Generation of stable transgenic parasite lines
Two sets of transgenic parasite lines were generated using the above mentioned
plasmids. In the first set, parent and three modified plasmids were electroporated into
PLKAHX strain. As a result, four transgenic parasite lines were generated to investigate
the transcriptional regulation of LDH1 in tachyzoites and bradyzoites. In the second set,
the parent plasmid and the two modified plasmids were electroporated into PLKAHX
strain. As a result, three transgenic parasite lines were generated to investigate the
translational suppression of LDH2 in tachyzoites.
Freshly lysed out Toxoplasma gondii tachyzyotes from confluent HFF monolayer
were scraped from culture plates, syringed through a 21-G needle to release the parasite
from host parasitophorous vacuole, filtered through a 3 pm membrane to remove host
cell debris and then sedimented by centrifugation at 2000-3000 rpm for 10 min at room
temperature. The collected parasite pellet was washed with Dulbecco’s phosphate
4-9

•

buffered saline supplemented with 0.1 g/1 Ca (DPBS) prior to electroporation. The
washed pellet was resuspended in 400 pi cytomix buffer (120mM KC1, 0.1 mM CaCL,
lOmM K 2HPO4 , KH 2 PO4 , pH 7.6, 2 mM EDTA, 5Mm MgCh) freshly supplemented
with 5mM glutathione and 2 mM ATP. Electroporation makes the cells sensitive to the
osmolarity and ionic composition of the medium. Use of potassium phosphate-based
cytomix buffer resembles the ionic composition of the cytosol and help increasing the
cell survival to a greater extent. lOpg of the purified Plasmid/transforming DNA was
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added to the parasite suspension in a 4mm sized electroporation cuvette. Using BTX
model 600 Electro Cell Manipulator (Genetronics) (250, current, 1.8 kEV, 25uF), this
mixture was subjected to electroporation and then incubated for 30 min at room
temperature. The electroporated parasites were then inoculated to a fresh confluent HFF
cells (Donald and Roos 1994). Stable populations were selected using 25 jig/ml
mycophenolic acid as an inhibitor to inosine monophosphate dehydrogenase (IMPDH)
and 50pg/ml xanthine as a substrate. Both of these were added to the culture media
(Donald and Roos 1998).

2.6.1 Differentiation of the parasites
HFF monolayers were infected with 4 xlO4 of the transgenic parasites and allowed
to grow in EDI medium. After four hours, all the remaining extra cellular parasites were
removed by aspirating off the EDI. Culture medium was replaced with RPMI 1640
medium, having 5% fetal bovine serum (FBS), 50mM HEPES, 20mg of antimycotic/L
and with pH 8.2. Parasites were allowed to grow in low CO 2 environment (0.4%) for five
days. RPMI medium lacks growth factors and has a high pH. This, along with low CO2
induces switching o f tachyzoites into bradyzoites.

2.7 Confirmation of transgene integration by PCR
Confirmation of clones with GFP reporter plasmids, and mycLDHl/LDH2
plasmids was done using PCR as described in general methods. PCR products were
visualized in 1.5% agarose gel.
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2.7.1 Confirmation of the UTR clones
Different set of primers were designed for the confirmation of the clone. Primer
set A has primers named 5PL1 and 3GFP1491 and was designed to amplify a 500-bp
long DNA sequence, encompassing an area from upstream region of LDH1 to GFP for
the confirmation of 5 'UTRGFP-HX and 3'5'UTRGFP-HX clones. The parent plasmid
p5'UTRGFP-HX was used as a positive control. Primer set B consists of primers named
5GFP 1667 and 3UTRL1 and was designed to amplify a 600-bp long DNA sequence that
covers the area from GFP to downstream region of LDH1 and was used for the
confirmation of 3 'UTRGFP-HX and 3'5'UTRGFP-HX clones. Primer set C, consisting
of primers 5GFPmyc and 3GFP1940 was designed to amplify 700-bp band from GFP
reporter. Parent plasmid p3'UTRGFP-HX was used as positive control. Wild type
parasite strain i.e. PLKAHX served as a negative control for all of these primer sets.

2.7.2 Confirmation of the mycLDHl/LDH2 clones
In order to confirm the transgenic LDH1 and to differentiate it from the native
LDH1 different pairs of primers were designed. Primer set D, that has primers LDH-ORF
sense and LDH-ORF antisense was designed to amplify a 300-bp band from the open
reading frame (ORF) of the LDH1 that was ligated in place of GFP. The genomic LDH1
o f toxoplasma however, has an intron of approximately 537-bp size within its ORF.
Primers could amplify a 300-bp band from transgenic LDH1 or 837-bp band using
genomic LDH1 as their template. Similarly mycLDH2 clone confirmation was carried out
using primer set E, having primers LDH2 forward and LDH2 reverse that amplifies a
480-bp band from the open reading frame of LDH2 that was ligated in the parent plasmid
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in place o f GFP. Again the genomic LDH2 of toxoplasma has an intron of 587-bp size
with in its ORF. The primers could amplify 480-bp band when transgenic LDH2 was
used as a template and a 1067-bp band when genomic LDH2 was used as template.
Sequences o f these primers are listed in Appendix A.

2.7.3 mycLDHl/LDH2 clone confirmation by restriction digestion
In order to further confirm the transgenic LDH expression, restriction enzymes
specific to LDH1 and LDH2 were used. PCR product (1 OOjllI) of transgenic LDH1 and
LDH2 were first phenol: chloroform extracted and then ethanol precipitated. Respective
DNA pellets were resuspended in 10 pi autoclave water and used for restriction
digestion. Restriction digestion was performed in a 15pi total volume having 2pl DNA,
1.5 pi of lOx enzyme buffer, 0.5 pi enzyme and 11 pi of sterile water. This mixture was
incubated at 37°C for overnight and then visualized in 1.5% agarose gel. For the
confirmation o f mycLDHl clone, HincII enzyme that cuts the ORF of LDH1 was used,
while PstI enzyme that cuts the ORF of LDH2 was used for the confirmation of
mycLDH2 clone.

2.8 Expression of reporter gene in T.gondii
Expression of GFP and mycLDHl/LDH2 were measured using western blot as
described in general methods.

42

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

2.8.1 Expression of GFP
In order to examine the expression of GFP gene products, a western blot analysis
was performed using polyclonal antibodies, in wild type and transgenic parasite lines.
Equal amounts of protein extracts from PLHAHX, mycHisGFP-HX, 35UTRGFP-HX,
3UTRGFP-HX, and 5UTRGFP-HX were immunoblotted and incubated with affinity
purified antibody specific to GFP raised in goat (1:500) Rockland Inc. Antigoat IgG-HRP
conjugate was used in 1:1000 dilution. Proteins from host HFF cells were also loaded in
equal amounts to eliminate the possibility of cross contamination. In order to compare
GFP expression with native LDH1 expression, the same blot was stripped with 0.1 M
Glycine. HC1 buffer (pH 2.5-3), washed twice with TBST and a western blot was
performed using rabbit antiLDHlserum (1:500) from Sigma. Anti-rabbit IgG-HRP
conjugate (Sigma) was used as the secondary antibody.

2.8.2 Expression of mycLDHl/LDH2
Equal amounts of protein extracts from PLKAHX, mycLDHl, mycLDH2 were
immuno-blotted and incubated with affinity purified antibody specific to

6 xHis

tag

(1:500) raised in rabbit (Rockland Inc). Anti rabbit-IgG-HRP conjugate (1:10,000) was
used as the secondary antibody. Protein extracts from human foreskin fibroblasts (HFF)
were also subjected to western blotting to make sure there is no cross contamination.
Equivalent amounts of the same protein preparations were subjected to western blot
analysis using antibody against LDH1 to ensure that comparable amounts of cell free
lysates were loaded and probed.
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2.9 Localization of GFP
Subcellular localization and abundance of GFP was monitored by measuring
immunofluorescence. Transgenic parasite lines as well as the wild type PLKAHX were
subjected to immunofluorescence assay using GFP-specific polyclonal antisera raised in
goats (1:200) from Rockland Inc. Anti goat IgG-rhodamine conjugated was used to
reveal the location of GFP. Nuclear staining was done using DAPI (1:15) which was used
as an internal control.

2.9.1 GFP localization in tachyzoites
In order to estimate the abundance of GFP among three test transgenic parasite
lines as compared to the transgenic positive control and the wild type, DAPI was used as
an internal control. Intensities of rhodamine fluorescence signals and that of DAPI were
quantified. The relative fluorescence was determined by the ratio of GFP signals with
reference to DAPI signals.

2.9.2 GFP localization in bradyzoites
HFF monolayers were grown in plates with cover slips; parasites were inoculated
and were allowed to invade for four hours in EDI medium. After that EDI was replaced
with RPMI medium that lacks growth factors and have high pH and parasites were
allowed to grow in low CO 2 environment for five days to induce switching to bradyzoites
as described in general methods. Parasites reside within a cyst in bradyzoite stage.
Fluorescein isothiocyanate (FITC)-conjugated Dolichos biflorus lectin (1:300) that
specifically binds to the N-acetylglucosamine moiety within the cyst wall was used as a
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marker for cyst wall development (Tomavo, 2001). Localization and abundance of GFP
was monitored, along with the presence of cyst wall, using GFP specific polyclonal
antisera raised in goat. A rhodamine conjugated anti goat was used to reveal the signals
of GFP as was done in tachyzoites. DAPI was used again as an internal control to stain
the nuclei.

2.10 Growth assay
In order to assess the growth rate and infectivity of parasites, plaque assays were
done. Freshly released parasites from wild type and all transgenic strains were stained
with 0.4% Trypan blue and counted under microscope. Live parasites were able to pump
out the blue dye and appeared transparent while dead parasite showed blue color.
Confluent HFF monolayers in 35mm culture plates were inoculated with 4-5 x 104
parasites from control and test strains. Parasites were allowed to grow undisturbed in
EDI medium for 8-10 days and then media was aspirated off. The infected monolayer
was rinsed with PBS, fixed with methanol (95%) for five minutes and then stained with
lx crystal violet ( 5x stock: 25g crystal violet in 250 ml methanol, volume made up to
1000ml with 1% ammonium oxalate). Monolayers were finally washed with PBS and
air-dried. Parasite plaques appear as irregular clear areas against violet background of
HFF monolayer.
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CHAPTER 3
RESULTS
In order to investigate the mechanism behind differential expression of LDH1 and
LDH2 during stage conversion the study was divided into two parts. The first part was
designed to elucidate the influence of 5' upstream and 3 'downstream sequence of LDH1
on the expression of LDH1 using GFP as a reporter system. The experiments in the first
part were aimed at understanding translational suppression of LDH1. The second part
was aimed at the investigation on how the expression of LDH2 in the tachyzoites and that
of LDH1 in bradyzoites, will influence the life cycle of T.gondii.

3.1 Translational suppression of LDH1
Four transgenic parasite lines were generated, as described in Materials and
Methods section 2.4.1, for the investigation of the translational suppression of LDH1
during stage conversion. These parasite strains were referred to as mycHisGFP-HX,
5'UTRGFP-HX, 3'5'UTRGFP-HX, and 3 'UTRGFP-HX. The strain mycHisGFP-HX
was used as a positive control while the remaining three were tested strains. Their names
reflect the genetic material carried by them. For example, the strain 5'UTRGFP-HX has a
626-bp upstream region of LDH1 to control the expression of reporter GFP and
HXGPRT as a selectable marker. All parasite lines were generated using PLKAHX. Thus
PLKAHX served as a negative control for the study.
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3.1.1 Confirmation of transgene integration
To determine that the GFP reporter system was integrated into the genome of the
transgenic parasites, PCR analysis was performed using genomic DNA as starting
material. In order to amplify a specific segment of the reporter system, several pairs of
PCR primers were designed as shown in Figure 3.1 A. Using primer set A (Material and
Methods 2.7.1) a 500-bp band was amplified from 5 'UTRGFP-HX and 3'5'UTRGFPHX as shown in left part of Figure 3.1 B. This band was not amplified when genomic
DNA from PLKAHX, mycGFP-HX or 3'UTRGFP-HX was used as template. This
further confirmed the specificity of the primers for the clones. Parent plasmid
p3'5 'UTRGFP-HX was used as a positive control for PCR and gave a very bright
prominent band as compared to the clonal parasite strains depending upon level of
expression.
Similarly when the genomic DNA from all transgenic and wild type parasite
strains were subjected to PCR amplification using primer set B (Materials and Methods
2.7.1) that uses GFP-3'UTR of LDH1 as a template, a 600-bp band was amplified from
3'5'UTRGFP-HXand 3 'UTRGFP-HX as shown in right part of Figure 3.1 B. Again this
band did not appear when the genomic DNA from wild type, mycHisGFP-HX, and
5 'UTRGFP-HX were used as template again indicating the specificity of the primers.
Parent plasmid p3'5 'UTRGFP-HX was used as a positive control and produced a
prominent band as compared to the parasite clones. Primer set C somehow did not
produce any band when used with genomic DNA from transgenic strains, even though it
amplified a 700-bp band from parent plasmid pTub 8 mycHisGFP-HX data not shown
here.
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Figure 3.1
Confirmation of transgene integration
Legend
A. Schematic presentation of the primer design. Primer set A has 5' and 3' primers
named 5PL1 and 3 GFP 1491 that were designed to amplify a 500-bp band from DNA
segment encompassing an area from 5'UTRLDH1 to GFP. This set of primers was used
for the confirmation of upstream region of the clones. Primer set B has 5' and 3' primers
named 5GFP1667 and 3UTRL1 and were designed to amplify a 600-bp band using DNA
segment from GFP to 3'UTRLDH1 as their template. This set of primer was used for the
confirmation of down stream region of the clones. Primer set C, with the primers
5GFPMYC and 3GFP1940, was designed to amplify 700-bp is also shown.

B. Image of an agarose gel that resolved the PCR product. The set of primers are labeled
on top of the name of the parasite strain tested. The expected band migrated at ~500-bp
when primer set A was used and ~600-bp when primer set B was used. Genomic DNA
was used as a template from wild type (PLKAHX) and transgenic strains i.e.
mycHisGFP-HX (GFP), 5 'UTRGFP-HX (5H), 3'5'UTRGFP-HX (35C) and 3 'UTRGFPHX (3B) respectively. Parent plasmid p3'5 'UTRGFP-HX (p35GFP) was used as a
positive control for the PCR for both primer sets.
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3.1.2

Expression profile of GFP under the control of upstream and

downstream regions of LDH1
In order to evaluate whether the GFP reporter system is being expressed under the
control o f LDH1 upstream and downstream sequences, a western blot analysis was
performed using polyclonal antibody raised against GFP. Protein lysates were prepared
from wild type PLF1AHX (negative control), and transgenic control (mycHisGFP-HX)
and transgenic tests (5'UTRGFP-HX, 3'5'UTRGFP-HX, and 3 'UTRGFP-HX). Equal
amounts of protein extracts from each strain were analyzed by immunobloting and
incubated with affinity purified antibody specific to GFP. Another parasite strain
(HEDL), which constitutively expresses GFP fusion protein was used as positive control
in early experiments (Figure 3.2 A). Low GFP expression was observed in all transgenic
tests as compared to that of transgenic control (Tub8mycHisGFP-HX). Negative control
PLHAHX did not show any GFP band, as expected. In addition, no band was detected in
protein samples from HFF host cells as shown in Figure 3.2 B. Size of the GFP band
showed approximately at 57 kDa while the expected GFP band has 35 kDa molecular
weight.
In order to compare GFP expression with native LDH1, the same blot was
stripped and western blot was performed using antibody against LDH1. LDH1 with a
molecular weight of 35 kDa gave very prominent band in each parasite strain tested
indicating that the amount of protein loaded was equal in each lane and the difference in
GFP expression observed in transgenic tests could be due to the difference in promoter
and downstream sequences.
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Figure 3.2
Expression profile of GFP under upstream and downstream region of LDH1
Legends
Images of three different western blot analyses are shown.
A. Upper panel shows GFP expression performed on wild type (PLHAHX), transgenic
positive control i.e. mycHisGFP-HX (GFP), test strain 35UTRGFP-HX (35C) and
another parasite strain HEDL that expresses a GFP fusion protein and was used as
positive control for the experiment. HEDL and transgenic control mycHisGFP-HX
showed prominent bands. Transgenic test, 35C however did not show any band. Lower
panel is showing the expression of LDH1 in the same strains when equal amount (20pg)
of protein was probed with anti LDH1 antibody. All the strains gave strong LDH1 bands
at 37kDa.
B. Upper panel shows GFP band appeared at 57 kDa when negative control (PLKAHX),
transgenic positive control mycHisGFP-HX (GFP), and three transgenic test strains
5UTRGFP-HX (5H), 35UTRGFP-HX (35C), and 3UTRGFP-HX (3B) were probed with
anti-GFP antibody. Protein lysates from host HFF were also subjected to western blot
analysis to rule out the possibility of antibody cross reaction with host proteins.
Transgenic positive control gave very prominent bands as compare to the three transgenic
test strains. Negative control and HFF did not show any bands. Lower panel shows LDH1
expression in all the strains tested.
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3.1.3 mRNA levels
In order to determine the level of mRNA among transgenic test strains and to
compare it with the wild type, RNA was isolated from wild type and transgenic strains
and reverse transcription was performed. In order to check the quality of cDNA, the
resulting RT product from transgenic control mycHisGFP-HX (GFP) was subjected to
PCR using primer set C and another primer set LDH (sense and antisense). Primer set
LDH was able to amplify DNA from the complimentary DNA of mycHisGFP-HX (GFP)
while primer set C did not produce any band from the same cDNA template. Plasmid
pmycLDHl(pmycLl) was used as a positive control for the PCR reaction using the same
primer LDH. Several attempts were made but did not work. Another primer set
5'T7GFPmut2 and 3'T7GFPmut was also tested with the genomic DNA from wild type
and transgenic tests, but a non specific band appeared (data not shown here). This band
appeared with genomic DNA from RHAHX also. Thus primer set C could not be used for
PCR from cDNA of transgenic Control.
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Figure 3.3
Measurement of mRNA level
Legend
Image of an agarose gel showing RT-PCR from wild type (PLKAHX),
mycHisGFP-HX (GFP), and 3UTRGFP-HX (3B) strains. Primer set C and primer LDH
were used. Primer set LDH successfully amplified 300-bp band from mycHisGFP-HX
cDNA. No product was made using primer set C.
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3.1.4 Localization of GFP gene product
In order to determine whether the GFP reporter was expressed in a similar fashion
as that of LDH 1, levels of GFP expression were monitored by immunofluorescence and
its subcellular localization was determined using immunolocalization in both stages of
parasite life cycle (Figure 3.4). Transgenic parasite strains, as well as the wild type
(PLKAHX) were subjected to immunofluorescence assay using GFP-specific polyclonal
antisera raised in goats. A rhodamine conjugated secondary antibody was used to reveal
the abundance and location of GFP since a direct green fluorescence from the transgenic
strains could not be detected. Nuclear staining was performed using DAPI. When merged
to DAPI images, Rhodamine signals were limited to cytoplasm indicating that GFP has a
cytoplasmic localization.

3.1.4.1 GFP localization in tachyzoites
In order to estimate the abundance of GFP among the three test transgenic
parasite lines as compared to the transgenic positive control and that of wild type, DAPI
was used as an internal control. Intensities of rhodamine fluorescence signals and that of
DAPI were quantified. The relative fluorescence was determined by the ratio of GFP
signals with reference to DAPI signals. The positive control and the three test strains
showed GFP in more or less same amount. The negative control showed some
background noise signals.

55

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Figure 3.4
Localization of GFP in Tachyzoites
Legend
A. Immunofluorescence assay performed with transgenic and wild type parasites in
tachyzoite stage. Phase contrast micrographs are shown in upper panel and those of
immunofluorescence labeling in the lower panels. DAPI was used to label nucleus of
human foreskin fibroblasts and of parasites. Rhodamine-labeled sheep anti-goat IgG
was used to reveal the immunoreactive protein recognized by anti-GFP. All
transgenic strains showed cytoplasm localization of GFP when compared with
nuclear staining by DAPI.
B. GFP fluorescence measured and recorded by the software provided with the
microscope. GFP levels were compared with that of DAPI as an internal control is
shown in graphical form. Level of GFP expression is approximately the same in all
transgenic strains. The negative control also showed some noise signals. The error
bars are representing standard deviation.
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3.1.4.2 GFP localization in bradyzoites
In order to determine the effect of upstream and downstream regions of LDH1 on
GFP expression during bradyzoite stage, the tachyzoites were switched to bradyzoite.
The differentiation was done by changing EDI medium to RPMI and growing the
parasites in low CO2 environment. Once the parasite switches to bradyzoites they form a
cyst around them and the rate of parasite replication slows down. Parasite metabolism
changes with the differentiation and instead of LDH1, the parasite now expresses LDH2,
even though the mRNA of LDH1 is reported to be found in both stages. Fluorescein
isothiocyanate (FITC)-conjugated Dolichos biflorus lectin that specifically binds to the
N-acetylgalactosamine moiety within the cyst wall was used as a marker for cyst wall
development (Tomavo, 2001). FITC conjugated Dolichos biflorus lectin was used to stain
the cyst wall and as an indicator of bradyzoite differentiation. RJhodamine-labeled sheep
anti-goat IgG was used to reveal the immunoreactive protein recognized by anti-GFP.
Localization and abundance of GFP was monitored, along with the presence of cyst wall.
DAPI was used again as an internal control to stain the nuclei (Figure 3.5). GFP levels
were found decreased with the bradyzoite differentiation.
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Figure 3.5
Localization of GFP in bradyzoites
Legend
A. Immunofluorescence assay performed with PLKAHX and all the transgenic strains.
Phase contrast micrographs are shown in upper panel and those of immunofluorescence
labeling in the lower panels. Nuclear staining was done by DAPI, shown in panel 2, and
was used as internal control for GFP expression and cyst wall staining. Cyst wall
development was measured and shown in panel 3. GFP localization and abundance was
measured by the rhodamine conjugated anti-GFP and shown in the last panel. Transgenic
strains showed a lowered level of GFP expression but comparatively high levels of Nacetylgalactoseamine that served as an indicator of cyst wall development. Rhodamine
fluorescence as a measure of GFP expression and FITC fluorescence as a measure of Nacetylgalactoseamine expression were compared with that of DAPI as an internal control
to calculate the relative fluorescence units (RFU). Fluorescence was measured and
recorded by the software provided with the microscope. Level of GFP expression was
approximately the same in all transgenic strains and was much lower when compared to
the N-acetylgalactoseamine expression.
B.. Comparison of GFP levels (RFU values) in both stages is shown in graphical form.
GFP levels were decreased significantly in all transgenic strains when tachyzoites were
switched to bradyzoites. The negative control (PLKAHX) also showed noise signals for
GFP expression. Error bars are showing standard deviation.
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Figure 3.5
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3.1.5 Growth Assay:
In order to determine the effect of plasmid insertion on parasite growth,
infectivity and growth of transgenic parasite strains was determined by
performing plaque assay. Equal number of parasites (4-5 x 104) was inoculated
and allowed to grow undisturbed for 8-10 days. Then number of plaques formed
were counted and are shown in Figure 3.6. Since parasite invasion is coupled with
its infectivity, the number of plaques formed is taken as a measure of parasite
growth.
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Figure 3.6
Measurement of growth
Legend
Number of plaques formed by each parasite strain is shown in graphical
form. Wild type and transgenic strains were allowed to grow for 8-10 days.
Growth rate is almost similar in all strains showing that plasmid insertion did not
affect the growth rate of the parasites. The error bars represent standard deviation.
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3.2 Transcriptional regulation of LDH2
Two transgenic parasite lines were generated to study transcriptional regulation of
LDH2 in tachyzoites. These transgenic strains were named mycLDHl-HX and
mycLDH2-HX respectively. Parasite strain mycHisGFP-HX served as negative control
for the study.

3.2.1 Confirmation of transgene integration
To determine that the LDH1/LDH2 was integrated into the genome of the
transgenic parasites, PCR analysis was performed using genomic DNA as the starting
material. In order to amplify a specific segment of the reporter system, different pair of
PCR primers were designed (Figure 3.7 A). The parasite has genomic LDH1 and LDH2
also, but both o f them have an intron at same relative position and approximately of the
same size i.e. 538-nucleotides in LDH1 and 588 nucleotides in LDH2. This fact was
exploited to differentiate between transgenic and native LDH1 and LDH2 expression. In
order to confirm the transgenic LDH1 expression and differentiate it from the native
LDH1, primer set D was used. Transgenic parasite line produced both 300 and 837-bp
band when subjected to PCR amplification. PLKAHX and mycGFP-HX could only give
837-bp band but not the 300-bp band, which further confirms the specificity of the
primers (Figure 3.7 B).
For the confirmation of mycLDH2 clones, primer set E was used that amplifies a
480-bp band from the ORF of transgenic LDH2. The two transgenic test strains have both
genomic and transgenic LDH2 and produced both the bands when subjected to PCR
amplification. On the other hand, PLKAHX, being a negative control could amplify only
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1067-bp band but not the 480-bp band further confirming the specificity of these primers.
Plasmids pmycLDHl and pmycLDH2 were used as a positive control and gave very
intense bands when used with primer set for LDH1 and LDH2 respectively (Figure 3.7
B).
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Figure 3.7
Confirmation of transgene integration
Legend
A. Schematic presentation of primer design. Two different set of primers were designed
for clone confirmation. Primer set D was designed to synthesize a 300-bp band using
LDH1 ORF as template as shown below. Primer set E was designed to amplify a 480-bp
band using LDH2 ORF as template.
B. Image o f an agarose gel resolving PCR product. The set of primers are labeled under
the name o f the parasite strain tested. The expected band migrated at 837-bp in all the
strains and 300-bp migrated only in transgenic mycLDHl strain, when primer set D was
used. Similarly the expected band migrated at 1067-bp in all strains and 480-bp band
migrated only in transgenic mycLDH2 strain when primer set E was used. Plasmid
pmycLDHl-HX (pLl) and pmycLDH2-HX (pL2) were used as positive control for the
PCR for primer set D and E respectively. Genomic DNA amplification from wild type
PLKAHX, transgenic control mycGFP-HX (GFP) and transgenic test strains mycLDHlHX (L1C) and mycLDH2-HX (L2B) are shown in order.
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3.2.2 Confirmation of transgene by restriction digestion
In order to further confirm the transgenic LDH expression, restriction enzymes
were used. PCR product from transgenic strains and that of wild type were first phenol:
chloroform extracted and then ethanol precipitated. The respective DNA pellets were
resuspended in water and used for later digestion reaction.

3.2.2.1 Confirmation of mycLDHl
For the confirmation of mycLDHl, HincII enzyme was used that cuts the 300-bp
tb
band amplified from transgenic LDH1 at the 180 nucleotide, resulting into two bands of
180 and 127-bp. HincII cuts at nucleotide 180 cleaving the 837-bp band amplified from
genomic LDH1 into 180 and 657 nucleotide bands. Transgenic strain, mycLDHl shows
both 180-bp and 657-bp bands confirming the presence of transgenic LDH1 in parasites.
PLKAHX showed only the 657-bp band but not the 180 bp band.
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Figure 3.8
mycLDHl Clone confirmation by restriction digestion
Legend
HincII-digested (D) and undigested (U) samples are shown from the parent plasmid
pmycLDHl (pLl), transgenic parasite strain mycLDHl (mycLIC) and the negative
control (PLKAHX). Digestion of 837 nucleotide DNA strand from genomic LDH1
resulted into 180 and 657 nucleotide bands in both the negative control and the transgenic
strain. However, 300-bp from transgenic LDH1 was digested into two bands of 180 and
127 nucleotides transgenic strain.
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3.2.2.2 Confirmation of mycLDH2
PstI enzyme was used for the further confirmation of mycLDH2 expression. PstI
cuts the 500-bp transgenic LDH2 at nucleotide 252 cleaving it into two bands of
approximately 250-bp size, while the 1087 nucleotide long native LDH2 is cleaved into
252 nt and 835 nt long DNA strands. PCR product from PLKAHX and mycLDH2-HX,
using primer set E, was subjected to PstI digestion. 1087-bp native LDH2 from both wild
type and transgenic strain was cut into 835 and 252bp band. PstI cut 500-bp transgenic
LDH2 into two bands of approximately 250-bp size. PCR product from parent plasmid
pmycLDH2 (pL2) was used as positive control for the digestion reaction and 500-bp
band was cut into 250-bp band as shown in Figure 3.8.
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Figure 3.9
mycLDH2 clone confirmation by restriction digestion
Legend
Pstl-digested (D) and undigested (U) samples are shown under the name of the parasite
strains i.e. wild type (PLKAHX) and transgenic strain mycLDH2-HX (mycL2B). 1087bp native LDH2 band from both wild type and transgenic strain was digested by PstI and
the resulting bands migrated at 835 and 250-bp. While 500-bp transgenic LDH2 band
was digested into 250-bp band. 500-bp PCR product from parent plasmid (pLl) was also
digested into 250-bp band. PCR product from the parent plasmid pmycLDH2-HX (pL2)
served as positive control for the digestion reaction.
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3.2.3 Expression profile of mycLDHl
In order to examine the expression of the mycLDHl gene product, western blot
analysis was performed. Equal amounts of protein extracts from PLKAHX, mycLDHl,
and mycLDH2 were immuno-blotted and incubated with affinity purified antibody
specific to 6xHis tag. Protein extracts from human foreskin fibroblasts (HFF) were also
subjected to western blotting to rule out the possibility of cross contamination. A strong
band was detected in mycLDHl as compared to mycLDH2 at approximately 37kDa.
However, when the same experiment was repeated after several passages, did not show
this band using myc-antibody.
Equivalent amounts (10-15pg) of the same protein preparations were subjected to
western blot analysis using antibody against LDH1 to ensure that comparable amounts of
cell free lysates were loaded and probed. All of them gave the same intensity band for
LDH1 at 37kDa.
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Figure 3.10
mycLDHl expression
Legend
Images of three different western blots analyses are shown.
A. upper panel shows western blot of the transgenic and wild type parasites using antiHis antibody. Two different amounts of mycLDHl were loaded. A strong band appeared
at 37kDa for mycLDHl strain while a faint band appeared in mycL2 strain. The band
appeared in PLKAHX was due to overflow of mycLl sample in the adjacent well. The
protein lysates from host HFF did not show any band. The lower panel shows the
expression of LDH1 in all these strains when equal amount of protein was loaded and
probed with anti-LDHl. Equal intensity bands appeared at 37 kDa. No band was detected
in HFF using either antibody.
B. Western blot that was repeated after several parasite passages (15-20) using anti-His
antibody. No signals were revealed, however when the same blot was stripped and
reprobed with anti-LDHl antibody gave prominent bands at 37 kDa showing LDH
expression.
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CHAPTER 4
DISCUSSION

The differentiation between actively replicating tachyzoites and slowly dividing/
encysted bradyzoites plays an important role in the pathogenesis of T. gondii, especially
in patients with lowered immunity. From the previous studies it has been established that
T. gondii expresses two distinct lactate dehydrogenases (LDH) at different stages: LDH1
during tachyzoite and LDH2 during bradyzoite stage (Yang and Parmley, 1997).
Mechanism of distinct expression is not well understood, however. LDH is an important
glycolytic enzyme which catalyzes the interconversion of lactate and pyruate using
NADH as a coenzyme. Under anaerobic conditions when glycolysis becomes the only
pathway to generate energy, LDH plays an essential role. Yang and Parmely (1997) have
clearly shown that mRNA for LDH1 is present in both stages but translated only in
tachyzoites not in the bradyzoites, indicating a translational suppression of LDH1 in
bradyzoites. On the contrary, mRNA for LDH2 is present only in bradyzoites but not in
tachyzoites suggesting a transcriptional regulation of LDH2 during this stage. LDH2
mRNA stability was not measured in this study, hence it is not clear whether high mRNA
levels are due to an increase in mRNA stability or because of transcriptional activation of
LDH2 gene. Using a CAT reporter with the putative promoter sequences of LDH1 and
LDH2 they also demonstrated that in the tachyzoites, CAT expression under LDH1
promoter sequence was high and reduced four fold with the differentiation to bradyzoites.
On the other hand no CAT activity was found in tachyzoites when CAT expression was
under LDH2 promoter control. However, it increased to forty-five fold upon switching to
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bradyzoites. Studies done in other eukaryotic systems also suggest a possible role of
untranslated regions in gene expression (Park et al., 2001). Regulatory activities of 5' and
3 ' untranslated regions have been reported in human aggrecan gene where untranslated
regions exerted differential effects on two different types of promoters (Wilmot et al.,
1998).

4.1 Translational suppression of LDH1
The expression of GFP under the control of upstream and downstream sequence
o f LDH 1 was determined by western blot analysis. GFP was tagged with ten amino acids
of myc-epitope and 8x His tag at its amino terminus. Anti-myc antibody and anti-His
antibody were used in determining GFP expression but signals were not detected (data
are not shown). A possible reason could be that these short amino acid tags were masked
by the folding o f GFP during translation. However, GFP was detected using the anti-GFP
antibody, even though the signals were not very strong, especially in transgenic strains, as
compared to the transgenic control line, mycHisGFP-HX (Figure 3.2). This could be due
to the low abundance of GFP. The observed low level of GFP could be due to the
difference in the controlling promoter. TUB8 promoter is a stronger promoter than the
upstream region of LDH 1 used in 5UTRGFP-HX and 35UTRGFP-HX. Moreover, the
expression of GFP in the control line could also be controlled by the 3'-UTR isolated
from the major surface antigen (SAG1). 35UTRGFP-HX and 3UTRGFP-HX that has the
downstream sequence of LDH 1 also showed low levels of GFP. Attempts were made to
determine the levels o f GFP mRNA by RT-PCR, however these were unsuccessful in
obtaining any PCR product using primer set C, even though other primer sets worked
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with the cDNA from RT reaction, for example primer set D (Figure 3.3). The primer set
C (Material and Method, section 2.7.1) was aimed to amplify whole GFP including myctag. This primer set did not give any PCR product when it was used with genomic DNA
of transgenic parasites also. A new set of primer should be made aiming to amplify first
the 350 nt from GFP starting from 1243 nt to 1600 nt in the parent plasmid and can be
used for both amplifying GFP from genomic DNA and measuring mRNA level from
cDNA. Northern blot analysis can also be used to determine the mRNA levels of GFP,
but it requires more starting materials, could be less sensitive than RT-PCR and slight
degradation o f RNA sample would greatly affect the ability to quantitate the mRNA
expression. Without measuring mRNA level, it is not clear if the lowered GFP expression
is due to alteration in mRNA stability and subsequent translation. The expected size of
the band was 37 kDa, while the GFP band was detected at approximately at 57 kDa. This
band can not be regarded as false positive because it was visible when run along with the
protein lysates from HEDL strain which expresses a GFP fusion protein. The difference
in the molecular weight could be due to the readthrough translation of mRNA. Stop
codon in Colorado tick fever virus (CTFV) has been reported to be a “leaky terminator”
allowing readthrough translation. As a result truncated termination protein and full length
readthrough protein are made and serve as structural and non-structural component of the
virus respectively (Fauziah et al., 2004). There are three stop codons in 3'UTR of SAG1
at nucleotide position 72, 81 and 135 that could give three different proteins with
molecular weights 48, 49 and 57 kDa respectively in mycGFP and 5'UTRGFP-HX
strains. There are four stop codons in 3'UTRLDH1 at nucleotide positions 216, 411, 651
and 663 which could give three different proteins with the molecular weight 48, 58, and
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70 kDa respectively in 3'UTRGFP-HX and 3 '5 'UTGFP-HX transgenic strains. There are
different possibilities in case the readthrough occur but why 57 kDa protein appeared in
particular is debatable.

GFP localization was found to be cytosolic in all transgenic strains, which is in
accordance with the endogenous LDH that is a cytosolic enzyme. Levels of GFP
expression among transgenic and control strains during tachyzoite stage were not
significantly different, even though the control strain showed the highest expression. The
detection o f GFP expression was observed to be better using IFA analysis as compared to
that of western blot analysis. This could be due to the high sensitivity of detection of IFA
technique. Negligible amount of noise signals were detected in wild type which could be
due to the variation in signal recording. The transgenic parasite strains, their respective
upstream and down stream sequences and the resulting GFP expression and localization
are shown in tabular on next page. Up arrow indicates an increase and down arrow
indicates the decrease in intensity of expression of GFP by the detection method used.
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GFP expression and localization during tachyzoite stage is the highest in the
control where the controlling elements are TUB 8 promoter and 3UTR SAG1. The
intensity of expression was affected when the controlling elements were replaced with
upstream and/or downstream sequence of LDH 1.
Levels o f GFP were found greatly reduced when measured in bradyzoite stage as
shown in Figure 3.5. Bradyzoite stage resembles to anaerobic condition where parasite
metabolism is changed significantly to adapt to the surrounding environment. The
reduction in GFP expression during bradyzoite stage could be due to the upstream and
downstream region of LDH1. However, from these results it is hard to say that the
decrease in expression is due to low transcription or low translation. If the level of
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mRNA in all transgenic strains is measured and is found equal, it would clearly establish
that lowering of expression is occurring at translation level.
Growth rate was found approximately the same in all transgenic strains indicating
that the plasmid insertion by electroporation does not affect the growth and infectivity of
the parasites. Growth rate of the wild type was found to be a bit higher as compared to
the transgenic control and test strains.

4.2 Transcriptional regulation of LDH2
The other two transgenic strains were generated to investigate the transcriptional
regulation of LDH2 in tachyzoites. PCR analysis from the genomic DNA of transgenic
parasites showed the presence of transgenes, however it is not clear that if the transgene
is integrated into the parasite genome and replicated with the parasite chromosome. The
plasmid integrates into the genome by homologous recombination which could results in
random integration, insertional mutagenesis, difference in copy number and silencing of
the introduced gene or nearby genes by de novo methylation. Western blot analysis was
performed to determine the expression of ORF of LDHs using anti-His antibody. Strong
signals were revealed from mycLDHl strain while very faint signal appeared in
mycLDH2 strain even though both the reporters were under the control of TUB 8
promoter and should have given constitutive expression. This could be due to difference
in copy number of the transgene. However, when the same experiment was repeated after
several parasite passages (15-20), these signals were not detected. Because of the
selection pressure, only the transformed parasite could survive and the untransformed
would gradually die with the continued drug selection, even if they have survived during
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first few passages. However, the parasites kept growing but the reporter expression
vanished i.e. selectable marker is being expressed in the parasites but not the reporter.
How this partial transgene expression could have happened is difficult to explain in
T.gondii.

4.3 Future Directions
Translational suppression
In order to further confirm and clearly establish the role of upstream and down
stream sequences of LDH1 in translational suppression followings could be done,
1. To quantitate the level of GFP mRNA by RT-PCR to establish that the decrease in
expression is at translational level.
2. Determining mRNA Stability to rule out the possibility of mRNA being degraded
before transport to cytosol.

LDH2 misregulation
In order to better understand the transcriptional regulation of LDH2, unregulated
LDH expression and its effect on parasite phenotype would be monitored. The following
experiments could be done,
1. To investigate the effect of misregulation, parasites can be inoculated into the mice to
test their virulence. Characteristic symptoms of the disease will be monitored along with
their ability to make brain cyst as compared to the control.
2. To monitor if the overexpression of transgenic LDH2 in tachyzoites could force
parasite encystations, IFA could be done for the detection of cyst wall development.
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3. To differentiate the native LDH1 from myc-tagged transgenic LDH2, antibodies
against both of them conjugated to different fluorescent probe can be used. Co
localization o f both, if any, can be monitored by doing IFA
4. To determine the effects of transgenic LDH1 during bradyzoite stage, again phenotype
change can de monitored. To differentiate native LDH2 from myc-tagged transgenic
LDH1, specific antibodies conjugated to different fluorescent probe can be used. IFA
can be done to determine if any co-localization exists.
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APPENDIX A
List of Oligonucleotides and plasmids
Primers
Set A 5PL1

Set B

SetC

5 ' CACACTGGGTAGTGTCC3'

3GFP1491

5' GTCGTGCCGCTTC ATAT G 3 '

5GFP1667

5' GAATAC AACTAC AACT CC 3'

3UTRL1

5' CTCATGCTTGCACGCGTT 3'

5GFPMYC

5' ATGCAGGAGCAGAAGCTC 3'

3GFP1940

5' GCCATGTGTAATCCCAGC 3'

Set D LDH-ORF sense

SetE

Sequence

5 'ATGGCACCCGCACTGGT3'

LDH-ORF antisense

5' GCGGAAGCGACCAGTCGA 3'

LDH2 forward

5'ATGACGGGTACCGTTAG 3'

LDH2 reverse

5' AAATCGTGCCGAATCTA 3 '

3'LDHPacI

5 'CCCTTAATTAAGTGCCAAGCTTAAGA 3'

5 XDHx Nsil

5' GATTT CAG AATT CGGAT CC 3'

BamHI 3'UTR dws 780

5' AAAGGATCCTCTATGTATCATGGGC 3'

LDH1
PacI 3UTR ups 780LDH1

5' CCCTTAATTAAGCGTTGGCAAAACAGG 3'

Hindlll dws 600 LDH1

5' AAGCTT GCT GACTA A AAATG AGC 3'

Kpnl ups 600 LDH1

5' CCCGGTACCTGCTGTGCGAATGTGTC 3'

5' T7 GFPmut2

5' AAGAATTGTAATACGACTCACTA 3'

3' T7 GFPmut

5' GTGTCCAAGAATGTTTCC 3'
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Restriction map for control plasmid (pTUB8mycHisGFP-HX)

A m picillin

T U B S p ro m o te r

icoR11148

S e ll 5 2 3 7

pTU B 8inycH isG FP-H X
6418 bp

3UTRSAG1

Sac

HXGPRT

B am H I 2 2 9 4

E c o N I4 0 2 5

B sin l 3 6 9 2

Sequence of TUB8 prom oter (495-bp)
K p n l (653)
GGTACCGGGC
AGACGCGTGT
CCTGAGACGC
GCACCCTGAG
TCCTGGTTGG
ACATTTTGTT
ATTAGCAGAG
CTTCTCTTTG
CGACGCAACC
TTGTGTGAAG
C
EcoRI (1148)

CCCCCCTCGA
TCCAACCACG
GTGTTCTAAC
ACGCGTGTTC
ACCGGTGGAG
TGTTCTCTGT
AGTCCTCCTT
CGAGTGTGGT
CGCGCAGAAG
TTCTTGCGGA

CGGTATCGAT
CACCCTGACA
CACGCACCCT
AA GCTTGCCT
ATGCGCGCGC
GAACTTTTAG
GTTCCATTCT
AGAGAACAAG
ACATCCACCA
AAACTACTCG

AAGCTTAACC
CGCGTGTTCC
GAG ACGCGT G
GCATTGGGTG
ACGAAGGGGA
ATGTGTTAAA
CTCTTGAATT
CACTCGTTCG
AACGGTGTTA
TTGGCATTTT

ACAAACCTTG
AACCACGCAC
TTCTAACCAC
CGGTTGGTGA
TGTGTCAGAA
GGCGGCGAAT
TCGCCCTTTC
CCGTCCCTGA
CACAATCACC
TTCTTGAATT

Sequence of myc and His tags (75-bp)
30 nt Myc and 24 nt His tags (in bold) are shown in order.
CCTTTTTCGA CAAAAAATGC AGGAGCAGAA GCTCATCTCC GAGGAGGACC
TGGCCATGGC CATGCAGCAC CACCATCACC ACCATCACCA T
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Sequence of GFP (734-bp)
Nsil (1243)
ATGCATAGTA
TGAATTAGAT
GTGAAGGTGA
ACTGGAAAAC
TGGTGTTCAA
TCTTCAAGAG
TTCAAGGACG
AGACACCCTC
ACGGAAACAT
GTATACATCA
GACCCGCCAC
AACAAAATAC
TACCTGTCCA
CCACATGGTC
TGGATGAACT

AAGGAGAAGA
GGTGATGTTA
TGCAACATAC
TACCTGTTCC
TGCTTTTCAA
CGCCATGCCT
ACGGGAACTA
GTCAACAGGA
CCTCGGCCAC
TGGCCGACAA
AACATCGAAG
TCCAATTGGC
CACAATCTGC
CTTCTTGAGT
AT AC A A AGCT

ACTTTTCACT
ATGGGCACAA
GGA A A ACTTA
ATGGCCAACA
GATACCCAGA
GAGGGATACG
CAAGACACGT
TCGAGCTTAA
AAGTTGGAAT
GCAAAAGAAC
ACGGCGGCGT
GATGGCCCTG
CCTTTCGAAA
TTGTAACAGC
GCAGATGGTG

GGAGTTGTCC
CAATTCTTGT
ATTTTCTGTC
AGTGGAGAGG
CCCTTAAATT
TATTTGCACT
CTTGTCACTA
CTTTCTCTTA
TCATATGAAG CGGCACGACT
TGCAGGAGAG GACCATCTTC
GCTGAAGTCA AGTTTGAGGG
GGGAATCGAT TTCAAGGAGG
ACAACTACAA CTCCCACAAC
GGCATCAAAG
CCAACTTCAA
GCAACTCGCT
GATCATTATC
TCCTTTTACC
AGACAACCAT
GATCCCAACG
AAAAGAGAGA
TGCTGGGATT
AC AC AT GGC A
CTTAA
PacI (1974) continued...

Sequence of 3UTR SAG1 (320-bp)
PacI (1974)
TTAATCACCG
TGCAGCATGT
CAGGTGTCAC
AGCAAGCAGC
GGCGGACCTG
A ATAC ACAAG
CTTGCCCCCC

TTGTGCTCAC TTCTCAAATC GACAAAGGAA ACACACTTCG
GCCCCATTAT AAAGAAACTG AGTTGTTCCG
CTGTGGCTTG
AT CC AC AAAA ACCGGCCGAC TCTAAATAGG AGTGTTTCGC
GAAAGTTTAT GACTGGGTCC GAATCTCTGA ACGGATGTGT
GCTGATGTTG ATCGCCGTCG ACACACGCGC CACATGGGTC
ACAGCTATCA GTTGTTTTAG TCGAACCGGT TAACACAATT
CGAGGGGGGA TCC
BamH I (2294)

Sequence of HXGPRT
ATGGCGTCCA
GCCCATGTAT
TGCCCCCCCA
TTGGTCAAGG
CTTCGGCGAG
TCTTCAACCT
CGTGAGTCCA
CTACCAGAAC
TGTCAATCTT
ACCGGTTTCA

AACCCATTGA AGACTACGGC AAGGGCAAGG
ATCCCCGACA ACACCTTCTA CAACGCTGAT
CTGCAAGCCC TACATTGACA AAATCCTCCT
ACAGAGTTGA GAAGTTGGCG TATGACATCC
GAGTTGCACA TCATTT GCAT CCTGAAAGGC
TCTGATCGAC TACCTTGCCA CCATACAGAA
GCGTGCCCCC CTTCTTCGAG CACTATGTCC
GACAACAGCA CAGGCCAGCT CACCGTCTTG
TCGCGACAAG CACGTTCTGA TTGTTGAGGA
CCCTCACCGA GTTCGGTGAG CGCCTGAAAG

GCCGTATTGA
GACTTTCTTG
CCCTGGTGGA
ACAGAACTTA
TCTCGCGGCT
GTACAGTGGT
GCCTGAAGTC
AGCGACGACT
CATCGTCGAC
CCGTCGGTCC
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CAAGTCGATG
ACAGCTTGAA
GTTGGTTGCT
CGCCGTCCTG

AGAATCGCCA CCCTCGTCGA GAAGCGCACA GATCGCTCCA
GGGCGACTTC GTCGGCTTCA GCATTGAAGA CGTCTGGATC
GCTACGACTT CAACGAGATG TTCCGCGACT TCGAGCACGT
AGCGACGCCG CTCGCAAAAA GTTCGAGAAG TAA
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Restriction map for plasmid p5UTRGFP-HX

PromoterllTRLDH 1

|)5UTRLDH 1GFP-HX
6549 bp
GFP

3UTRSAG1

HXGPRT

Upstream sequence of LDH1 (629-bp)
(Kpnl was introduced at 5' primer and Hindlll was introduced on 3 'primer. Hindll was made
blunt for cloning)
CCTGCTGTGC GAATGTGTgG CGTCGTTTAA AAACTGAACG
TTTCGTGCGA TCCCAGTTAC TCGGCGGCGT CTGAAGTGTG
CCACTTCAAG ACTGGGACGG GAACGAGAGT TGGACGACCA
GCGCTCGAAT TTTCTAAAGT TGGCCTCGGG TGTTCGTCCG
GCAGATGACG CAGCACTCCC CGCTGTTTAA GGAACTGGAA
TGCCCCTCTA ACATCGCACC GTCTCTGCGC ACCGTCGCTG
CCCGTCAGAG CGATATCGCG TTGCGTCACG TCATCGTTAT
TTCGGGAAAA TGGCAGCAGC GGGACGAACA CACTGGGTAG
GCTTCCGTCC CACCTGCGAA GGTGCGTCCA CCACAACTCA
TGCTGCGGCT GCGAATTCGC GTTCCCACAC TCGACCAGAT
TTCGATTTCC AAACGCGATT TATTCCAATC CGCCTTGTAG
GGTGCACTTT TGCACGTGTA CGCAAGACAG CTTCGCAGAC
AGCCTCCCGC TCATTTTTAG TCAGCAAAA
<----------------------------------------------------

TGGAAACCGT
TCCCTCTTCT
CTGGAAGCGG
GTATCTCGCA
TCTTGAACTG
TTCCGCGACT
TCGGTTTTTG
TGTCCACGCC
CGCGACTAGG
TTTTTTGATT
CAGACTAACC
AACATCTGGC
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Restriction map for plasmid p3UTRGFP-HX

Ampicillin
I1IVC

x

H is 1
p3UTRLDH 1GFP-HX
6 8 9 2 1>|)

GFP

3UTRLDH1

HXGPRT

Downstream sequence of LD H l (796-BP)
(PacI was introduced on 5 'primer and BamHI was introduced on 3 'primer for cloning)
CGTTGGCAAA
TTATACACGC
CGCGCTCGTC
CGGGTTGCAG
CCAGGGAAGT
TCCGTCGCTG
AAAAGCCTCT
ACAGCAACCG
CGCATGACTT
AAG ATCACAT
AGCGATAGGT
TTTTTTTTAC
GTGGTTGGTC
ATTTTTCAAC
CCGAAAGCTG
GAAAGCCGAC

ACAGpAGCGG
AATGCCACTTTACTGCGCGG GGCCCATGAT
GTTTGCAACG GAAGCGAAAA GACGGTTCCG GTTCGCACCA
CCGAAAAAGG
GAAGTCGCGG CGCTGTCGGTCAACGCTGTG
GTGCGTGCTT AAGCATCACA AAGTGGCAGA GCCATTTTGT
AGCGTCTCAA ACAGGTGAAC GCGTGCAAGC ATGAGAGGCA
CGTTCGCTCA CATATCCGAA
GGCAACAGAT TTTGGTCGGC
GCACAACCGT GGCAAGATGA TGGAAACAGT TCGTGTTTGG
CGTTCGCTCT
CACTCAAAAC CCTGTAGTCG AGAGGGGTGT
GGCTTTTGTG GGAGTGCCCA AATCGTCTGT GTTCGAGGTG
GTCCGCTGCA GT ACTGAAA A ACACTTGGTG CGCAGAGGCG
GCGCTGACTT TTTTTTTGTT
TGTTCAAGGA AGGCATCTTT
CGGTTGTCCA CTGTCATGTC GAAAACGTAG TCCGTGTGAA
CCCTGTTGTC
CTT TGTCTAG CCGCGCGTGT CTCATGGAGC
GTTGCTTCAA ACGAATGCTG GTTTCTCGAG TGCACCTGCA
CGGGAAATTC AAAATCTTTC
CCGACAATGC GGAGCCGTAC
GTGGGTTATT
TGGQ X A T G A TACATAGAGG AACTGG
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Restriction map for plasmid p35UTRGFP-HX

Ampicillin
PromoterUTRLDH 1

|>35UTRLDH1GFP-HX
7023 bp

myc'
His
GFP

3UTRLDH1
HXGPRT

Upstream sequence of LDH1 (629-bp)
(Primer 5PL1 is highlighted and was used for clone confirmation)
CCTGCTGTGC
TTTCGTGCGA
CCACTTCAAG
GCGCTCGAAT
GCAGATGACG
TGCCCCTCTA
CCCGTCAGAG
TTCGGGAAAA
GCTTCCGTCC
TGCTGCGGCT
TTCGATTTCC
GGTGCACTTT
AGCCTCCCGC

GAATGTGTCG CGTCGTTTAA AAACTGAACG
TCCCAGTTAC TCGGCGGCGT CTGAAGTGTG
ACTGGGACGG GAACGAGAGT TGGACGACCA
TTTCTAAAGT TGGCCTCGGG TGTTCGTCCG
CAGCACTCCC CGCTGTTTAA GGAACTGGAA
ACATCGCACC GTCTCTGCGC ACCGTCGCTG
CGATATCGCG TTGCGTCACG TCATCGTTAT
TGGCAGCAGC GGGACGAACA CACTGGGTAG
CACCTGCGAA GGTGCGTCCA CCACAACTCA
GCGAATTCGC GTTCCCACAC TCGACCAGAT
AAACGCGATT TATTCCAATC CGCCTTGTAG
TGCACGTGTA CGCAAGACAG CTTCGCAGAC
TCATTTTTAG TCAGCAAAA

TGGAAACCGT
TCCCTCTTCT
CTGGAAGCGG
GTATCTCGCA
TCTTGAACTG
TTCCGCGACT
TCGGTTTTTG
TGTCCACGCC
CGCCxACTAGG
TTTTTTGATT
CAGACTAACC
AACATCTGGC

Sequence of myc and His tags
(Primer 5GFPmyc is highlighted)
AATGCAGGAG CAGAAGC^CA TCTCCGAGGA GGACCTGGCC ATGGCCATGC
AGCACCACCA TCACCACCAT CACCAT
Sequence of GFP (734-bp)
(Primer 3GFP1491, 5GFP1667, and 3GFP1940 are highlighted in order. All were used for clone
confirmation)
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ATGCATAGTA
TGAATTAGAT
GTGAAGGTGA
ACTGGAAAAC
TGGTGTTCAA
TCTTCAAGAG
TTCAAGGACG
AGACACCCTC
ACGGAAACAT
GTATACATCA
GACCCGCCAC
AACAAAATAC
TACCTGTCCA
CCACATGGTC
TGGATGAACT

AAGGAGAAGA
GGTGATGTTA
TGCAACATAC
TACCTGTTCC
TGCTTTTCAA
CGCCATGCCT
ACGGGAACTA
GTCAACAGGA
CCTCGGCCAC
TGGCCGACAA
AACATCGAAG
TCCAATTGGC
CACAATCTGC
CTTCTTGAGT
ATACAAAGCT

ACTTTTCACT
ATGGGCACAA
GGAAAACTTA
ATGGCCAACA
GATACCCAGA
GAGGGATACG
CAAGACACGT
TCGAGCTTAA
AAGTTGGAAT
GCAAAAGAAC
ACGGCGGCGT
GATGGCCCTG
CCTTTCGAAA
TTGTAACAGC
GCAGATGGTG

GGAGTTGTCC CAATTCTTGT
ATTTTCTGTC
AGTGGAGAGG
CCCTTAAATT TATTTGCACT
CTTGTCACTA CTTTCTCTTA
TCATATGAAG CGGCACGACT
T<j CAGGAGAG GACCATCTTC
GCTGAAGTCA
AGTTTGAGGG
GGGAATCGAT
TTCAAGGAGG
AC A ACTAC AA
CTCCCACAAC
GGCATCAAAG
CCAACTTCA a
GCAACTCGCT GATCATTATC
TCCTTTTACC
AGACAACCAT
GATCCCAACG
AAAAGAGAGA
TGCTGGGATT
ACACATGGCA
CTTAA ^-------------------------------

Downstream sequence of LDH1 (796-BP)
(Primer 3UTRLlis highlighted and was used for clone confirmation)
CGTTGGCAAA
TTATACACGC
CGCGCTCGTC
CGGGTTGCAG
CCAGGGAAGT
TCCGTCGCTG
AAAAGCCTCT
ACAGCAACCG
CGCATGACTT
AAGATCACAT
AGCGATAGGT
TTTTTTTTAC
GTGGTTGGTC
ATTTTTCAAC
CCGAAAGCTG
GAAAGCCGAC

ACAGGAGCGG
AATGCCACTT
TACTGCGCGG GGCCCATGAT
GTTTGCAACG GAAGCGAAAA GACGGTTCCG GTTCGCACCA
CCGAAAAAGG
GAAGTCGCGG
CGCTGTCGGTCAACGCTGTG
GTGCGTGCTT AAGCATCACA AAGTGGCAGA GCCATTTTGT
AGCGTCTCAA ACAGGTG^AC GCGTGCAAGC. ATGAGAGGCA
CGTTCGCTCA CATATCCGAA GGCAACAGAT TTTGGTCGGC
GCACAACCGT GGCAAGATGA TGGAAACAGT TCGTGTTTGG
CGTTCGCTCT
CACTCAAAAC CCTGTAGTCG AGAGGGGTGT
GGCTTTTGTG GGAGTGCCCA AATCGTCTGT GTTCGAGGTG
GTCCGCTGCA GTACTGAAAA ACACTTGGTG CGCAGAGGCG
GCGCTGACTT TTTTTTTGTT
TGTTCAAGGA AGGCATCTTT
CGGTTGTCCA CTGTCATGTC GAAAACGTAG TCCGTGTGAA
CCCTGTTGTC
CTT TGTCTAG CCGCGCGTGT CTCATGGAGC
GTTGCTTCAA ACGAATGCTG GTTTCTCGAG TGCACCTGCA
CGGGAAATTC AAAATCTTTC
CCGACAATGC GGAGCCGTAC
GTGGGTTATT
TGGCCCATGA TACATAGAGG AACTGG
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Restriction map for plasmid pmycLDHl-HX

TUBSprinoter
m yc
His

t

|)TUB8mycHisLDH1-HX
6674 bp
LDH1

3UTRSAG1
HXGPRT

ORF of LDH1 (GenBank accession number U35118)
The LDH1 cDNA (990 nt) fragment was cloned at Nsil and PacI sites.
Primers LDHORF sense and LDHORF antisense are highlighted and were used for clone
confirmation

121

CCGCTCATTT

TTAGTCAGCA AAAATGGCAC

►
CCGCACTTGT GCAGAGGAGA AAGAAGGTGG

181

CCATGATTGG

CTCTGGCATG ATTGGTGGCA CTATGGGCTA CCTGTGCGCT CTCCGTGAGC

241
301

TCGCTGACGT
TGAGCCATGT

CGTTCTCTAC GATGTTGTCA AAGGTATGCC CGAGGGTAAG GCTCTTGACC
GACCTCCGTG GTCGACACCA ACGTTTCCGT CCGTGCTGAG ACTCTTACG

361

AGGCCGCGCT

CACCGGTGCG GACTGCGTTA

421
481

GCAAGCCCGA
GCGAGATCGG

CTCCGAGTGG AGCCGAAACG ATCTGCTCCC GTTCAACTCG AGATCATTC
TCA&AACATC AAGAAGTACT GCCCCAAGAC CTTCATCATC TGGTCACCA

TCGTTACCGC CGGTCTGACC AGGTGCCGG

541

ACCCGCTGGA

CTGCATGGTC AAGGTTATGT

GCGAGGCCTC TGGCGTCCCG CCAACATGA

601

TCTGCGGTAT

GGCCTGCATG CTCGACTCTG

GTCGCTTCCG CCGATACGTC CCGACGCGC

661

TG TCTG TCTC

TCCCCGCGAC GTCCAGGCCA CCGTCATCGG CACACACGGC ACTGCATGG

721

TCCCGCTTGT

CCGGTACATT ACCGTGAACG

781

GCGTAGTCAC

GGAGAAGCAG CTCGAGGAGA TCGCTGAGCA CACCAAAGTG CTGGCGGCG

841

AGATCGTCCG

CTTCCTCGGC CAGGGTTCCG

901

CCATGGCAAC

ATCCTTCTTG AACGACGAAA AGCGCGTCAT CCCGTGCAGT TGTACTGCA

961

ACGGAGAGTA

CGGCTTGAAG GACATGTTCA

1021
1081

GCATCGAGCG
CCGTCGACGA

CGTCATCGAG CTCGAGCTGA ACGAGGAGGA GAAGAAGCAG TCCAGAAGT
CGTCATGGCG CTCAACAAGG CGGTTGCTGC TCTTCAGGCG AAGCGTTGG

GCTACCCGAT CCAGAAGTTC TCAAGGACG
CTTACTACGC CCCCGCCGCA CCGCTGTCG
TTGGTCTCCC GGCCGTCATT GAGGCGCCG
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Restriction map for plasmid pmycLDH2-HX

Ampicillin

|)TUB8niycHisLDH2-HX
6665 bp
LDH2

3UTRSAG1

ORF of LDH2 (GenBank accession number U23207)
The LDH2 cDNA (981 nt) fragment was cloned in place of GFP.
Primers LDH2 forward and LDH2rewerse are highlighted and were used for clone confirmation.

GACGGGTACC GTTAGCAGAA AAAAAAGAT
TACCTTTG TG GCTTCGGGA

241

TGCTCGGCAT

TCGTACTTCA CTTCCACCAT

301

TGCAATGATT

GGTTCTGGCA TGATAGGAGG AACCATGGGC

361
421

GCTAGCCGAC GTCGTACTAT TCGACGTTGT AACAGGCATG CCAGAAGGGA GGCGTTGGA
TGATTCACAG GCGACAAGCA TTGCTGACAC GAACGTGAGC GTGACGAGCG AAACCAGTA
TGAGAAGATC GCCGGATCGG ATGTCGTAAT AATAACTGCA GGGCTGACCA GGTACCGGG

481
541

GAAGAGTGAC AAGGAGTGGA GCAGAAACGA CCTTTTACCG TTCAATG CAA AATCATTCG
CCCGCTTGCT TTTG TAA TTG AGTGACAAA

601
661

AGAGGTAGCG CAGGGAGTGA AGAAGTACTG
CCCGCTTGAC

TGCATGGTAA AGTGCTTTCA TGAAGCGAGC GGGTTACCAA AAACATGGT

721

TTGCGGAATG

GCGAATGTGT

781
841

GGAGATATCA CCTCGAGATA TTCAAGCTAC TGTTATCGGC ACACACGGTG CCACATGCT
GCCTCTCGCG CGTTATGTGA CGGTGAGTGG TTTCCCACTG CGAGAATTCA TAAAAAAGG

901

AAAAATGACT

961
1021
1081
1141
1201

TAGATTCGGC ACGATTTAGA CGCTTCATTG GGATCAGCT

GAGGCAAAAC TGGCAGAGAT

CGTAGAGCGT ACAAAGAAAG TGGGGGGGA
GTACTATGCT CCAGCCCTTT TGCTATAAC
AATGGCCCAG G CATTCTTAA AAGACGAGAA GAGAGTGCTC CCGTGCAGTG GTATTGCCA
GGGTGAGTAT GGGCTTCACG ATA TG TTTAT TGGTTTGCCG GCAGTTATAG CGGTGGGGG
AATCGAGCAG GTCATCGAAC TGGAGCTGAC ACATGAGGAA CAAGAGTGTT CAGGAAGTC
AGTTGATGAC GTGGTGGAAT TGAATAAGAG TTTAGCGGCG CTGGGTTGAA AAGTACGCA
GATTGTGAGA CTTTTGGGGC AAGGGTCAGC
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APPENDIX B
List of Buffers and Solutions

Cytomix Buffer

120mM KC1, 0.15 mM CaCl2, lOmM K2H P04, KH2P 0 4
pH7.6, 25mM HEPES pH7.6, EDTA 2mM, MgCl2
5mM

D-10 medium

10% cosmic calf serum,0.1% antimycotic in DMEM

Dulbecco’s phosphate

PBS buffer supplemented with 0.1 g/L Ca++

buffered saline (DPBS)
DNA gel loading buffer

0.025% Xyelene Cyanol FF, 0.025% Bromophenol
Blue, lOmM EDTA pH 8.0 and

98% deinonized

formamide
Edl medium

Eagle’s MEM, l%dFBS, 0.1 %1 antimycotic

HFF freezing medium

25%DMSO, 20% dFBS in DMEM

Lauri Bertani broth (LB broth)

lOg/L tryptone, 5g/L yeast extract and 0.17 M NaCl.
The broth was sterilized by autoclaving for 15 min.

Phosphate-buffered saline

0.14M NaCl, 2.7 mM KC1, lOmM Na2H P04 and

(PBS)

1.76mM KH2P 0 4 K2H P04 pH7.4

Protein lysis buffer

50pM HEPES, 5pM PMSF, 0.025% Triton xlOO, 20%
glycerol

Ponceau S

0.1 % Ponceau in 5% acetic acid solution

Resolving gel

9% acrylamide/bisacrylamide (37.5:1), 0.39 M Tris pH
8.8, 0.1% SDS, 0.1% APS and 0.04% TEMED
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RPMI1640

50mM HEPES pH8.2, 5% FBS, 20mg antimycotic/L

Running Buffer for protein

25mM Tris base, 192mM Glycine, 0.037% SDS pH 8.4

gel
SDS-PAGE destaining

45% methanol and 10% glacial acetic acid (v/v)

solution
SDS-PAGE loading buffer

0.5M Tris-HCl pH 6.8, Glycerol, 14.3M 2merceptoethanol, 10% SDS, 0.05% bromophenol blue.

SDS-PAGE staining solution

2.5g/L Coomassie blue in 40% methanol and 10%
glacial acetic acid (v/v)

Stripping buffer

0.25 M Glycine pH2.0 and 1% SDS

TBS

200mM NaCl, 20mM Tris pH 7.4

TBST

200mM NaCl, 20mM Tris pH 7.4 and 0.2 % Tween
(Polyoxyethylene Sorbitan Monolaurate)

T.gondii freezing medium

25% DMSO and 20% dFBS in ED 1

Transfer buffer

25mM Tris base, 192mM Glycine, 20% Methanol (v/v)
pH 8.4.

Tris EDTA buffer (TE)

10 mM Tris pH 8.0, and ImM EDTA

Tris-Acetate-EDTA (TAE)

40mM Tris-acetate and ImM EDTA
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